1
|
Vallée A, Carbonnel M, Ceccaldi PF, Feki A, Ayoubi JM. Postmenopausal endometriosis: a challenging condition beyond menopause. Menopause 2024; 31:447-456. [PMID: 38531006 DOI: 10.1097/gme.0000000000002338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/28/2024]
Abstract
IMPORTANCE AND OBJECTIVE Postmenopausal endometriosis is a complex condition that challenges the conventional belief that endometriosis resolves with menopause. Despite the cessation of menstruation, a subset of women continues to experience or develop endometriosis-related symptoms during the postmenopausal period. Thus, this review aimed to shed light on postmenopausal endometriosis, exploring its clinical features, diagnostic considerations, management approaches, and the potential impact on women's health. METHODS PubMed/Medline, Scopus, and Web of Science databases were used for the research, with only articles in English language, using the following terms: "postmenopausal endometriosis," "menopause," "management," "treatment," and "quality of life," from inception to 2023. DISCUSSION AND CONCLUSION The clinical features of postmenopausal endometriosis include persistent or recurrent pelvic pain, dyspareunia, bowel, or urinary symptoms and, occasionally, abnormal vaginal bleeding. The absence of menstrual cycles presents a diagnostic challenge, as the traditional diagnostic criteria for endometriosis rely on menstrual patterns. Visual cues may be less evident, and the symptoms often overlap with other gynecological conditions, necessitating a thorough evaluation to differentiate postmenopausal endometriosis from other potential causes. Management approaches for postmenopausal endometriosis encompass surgical intervention, hormonal therapies, pain management, and individualized care. Postmenopausal endometriosis significantly impacts the quality of life, sexual health, and long-term well-being of women. Understanding the clinical features, diagnostic challenges, and management approaches of postmenopausal endometriosis is crucial for healthcare professionals to provide effective care and to improve the quality of life of women affected by this condition.
Collapse
Affiliation(s)
- Alexandre Vallée
- From the Department of Epidemiology and Public Health, Foch Hospital, Suresnes, France
| | | | | | - Anis Feki
- Department of Gynecology and Obstetrics, University Hospital of Fribourg, Fribourg, Switzerland
| | | |
Collapse
|
2
|
Vallée A, Saridogan E, Petraglia F, Keckstein J, Polyzos N, Wyns C, Gianaroli L, Tarlatzis B, Ayoubi JM, Feki A. Horizons in Endometriosis: Proceedings of the Montreux Reproductive Summit, 14-15 July 2023. Facts Views Vis Obgyn 2024; 16:1-32. [PMID: 38603778 DOI: 10.52054/fvvo.16.s1.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/13/2024] Open
Abstract
Endometriosis is a complex and chronic gynaecological disorder that affects millions of women worldwide, leading to significant morbidity and impacting reproductive health. This condition affects up to 10% of women of reproductive age and is characterised by the presence of endometrial-like tissue outside the uterus, potentially leading to symptoms such as chronic pelvic pain, dysmenorrhoea, dyspareunia, and infertility. The Montreux summit brought a number of experts in this field together to provide a platform for discussion and exchange of ideas. These proceedings summarise the six main topics that were discussed at this summit to shed light on future directions of endometriosis classification, diagnosis, and therapeutical management. The first question addressed the possibility of preventing endometriosis in the future by identifying risk factors, genetic predispositions, and further understanding of the pathophysiology of the condition to develop targeted interventions. The clinical presentation of endometriosis is varied, and the correlation between symptoms severity and disease extent is unclear. While there is currently no universally accepted optimal classification system for endometriosis, several attempts striving towards its optimisation - each with its own advantages and limitations - were discussed. The ideal classification should be able to reconcile disease status based on the various diagnostic tools, and prognosis to guide proper patient tailored management. Regarding diagnosis, we focused on future tools and critically discussed emerging approaches aimed at reducing diagnostic delay. Preserving fertility in endometriosis patients was another debatable aspect of management that was reviewed. Moreover, besides current treatment modalities, potential novel medical therapies that can target underlying mechanisms, provide effective symptom relief, and minimise side effects in endometriotic patients were considered, including hormonal therapies, immunomodulation, and regenerative medicine. Finally, the question of hormonal substitution therapy after radical treatment for endometriosis was debated, weighing the benefits of hormone replacement.
Collapse
|
3
|
Vallée A, Ceccaldi PF, Carbonnel M, Feki A, Ayoubi JM. Pollution and endometriosis: A deep dive into the environmental impacts on women's health. BJOG 2024; 131:401-414. [PMID: 37814514 DOI: 10.1111/1471-0528.17687] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2023] [Revised: 09/05/2023] [Accepted: 09/14/2023] [Indexed: 10/11/2023]
Abstract
BACKGROUND The interaction between pollution and endometriosis is a pressing issue that demands immediate attention. The impact of pollution, particularly air and water pollution, or occupational hazards, on hormonal disruption and the initiation of endometriosis remains a major issue. OBJECTIVES This narrative review aims to delve into the intricate connection between pollution and endometriosis, shedding light on how environmental factors contribute to the onset and severity of this disease and, thus, the possible public health policy implications. DISCUSSION Endocrine-disrupting chemicals (EDCs) in pollutants dysregulate the hormonal balance, contributing to the progression of this major gynaecological disorder. Air pollution, specifically PM2.5 and PAHs, has been associated with an increased risk of endometriosis by enhancing chronic inflammation, oxidative stress, and hormonal imbalances. Chemical contaminants in water and work exposures, including heavy metals, dioxins, and PCBs, disrupt the hormonal regulation and potentially contribute to endometriosis. Mitigating the environmental impact of pollution is required to safeguard women's reproductive health. This requires a comprehensive approach involving stringent environmental regulations, sustainable practices, responsible waste management, research and innovation, public awareness, and collaboration among stakeholders. CONCLUSION Public health policies have a major role in addressing the interaction between pollution and endometriosis in a long-term commitment.
Collapse
Affiliation(s)
- Alexandre Vallée
- Department of Epidemiology and Public Health, Foch Hospital, Suresnes, France
| | - Pierre-François Ceccaldi
- Department of Obstetrics, Gynaecology and Reproductive Medicine, Foch Hospital, Suresnes, France
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines (UVSQ), Versailles, France
| | - Marie Carbonnel
- Department of Obstetrics, Gynaecology and Reproductive Medicine, Foch Hospital, Suresnes, France
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines (UVSQ), Versailles, France
| | - Anis Feki
- Department of Gynaecology and Obstetrics, University Hospital of Fribourg, Fribourg, Switzerland
| | - Jean-Marc Ayoubi
- Department of Obstetrics, Gynaecology and Reproductive Medicine, Foch Hospital, Suresnes, France
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines (UVSQ), Versailles, France
| |
Collapse
|
4
|
Farabet C, Pirtea P, Benammar A, De Ziegler D, Marchiori C, Vallée A, Ayoubi JM. The impact of paternal age on cumulative assisted reproductive technology outcomes. Front Med (Lausanne) 2024; 10:1294242. [PMID: 38298503 PMCID: PMC10828963 DOI: 10.3389/fmed.2023.1294242] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2023] [Accepted: 11/29/2023] [Indexed: 02/02/2024] Open
Abstract
Objective To investigate the impact of paternal age on cumulative live birth rate in ART. Design Retrospective single-center cohort study. Patients All female patients aged 18-43 years and male patients aged 18-60 years, who performed their first ART cycle between January 2018 and December 2020, were included. Main outcome measures The primary outcome, cumulative live birth rate (cLBR), was estimated following fresh or frozen embryo transfers issued from an ART cycle. Secondary outcomes included the cumulative pregnancy rate (cPR) and miscarriage rate. Subgroup analyzes were performed as follows: men <45 and ≥ 45; female <35, 35-38, and > 38 years. Results A total of 2,358 couples were included in this study. The sperm quantity of male patients within both age groups was divided in two groups: normal and abnormal, which were found to be in significantly equal proportions. There were significantly fewer current smokers in the male group ≥45. The cPR was 0.5301 in the group <45 and 0.3111 in the group ≥45, with a p-value <0.001. Analysis according to the female age revealed that, in the female group >38, the cLBR rate was 0.26 for men <45 and 0.19 for men ≥45, with a p-value of 0.061. Additionally, the cPR was 0.34 in the male group <45 and 0.21 in the group ≥45, with a p-value <0.001. In the female group between 35 and 38 years of age, the cLBR was 0.44 in the male group <45 and 0.3 in the male group ≥45, with a p-value of 0.031. The cPR was 0.49 in the male group <45 and 0.34 in the group ≥45, p = 0.036. Within the female group <35, we observed non-significant results. The miscarriage rate results were not significantly different for women ≤38. Conclusion According to the results from our study, male age ≥ 45 has a significant impact on cumulative ART outcomes.
Collapse
Affiliation(s)
| | - Paul Pirtea
- Department of Obstetrics, Gynecology and Assisted Reproduction, Hospital FOCH, Suresnes, France
| | | | | | | | | | | |
Collapse
|
5
|
Stoeklé HC, Sekkate S, Ayoubi JM, Bennouna J, Beuzeboc P, Hervé C. Vaccination against HPV: Easier said than done? Hum Vaccin Immunother 2023; 19:2266935. [PMID: 37822281 PMCID: PMC10572029 DOI: 10.1080/21645515.2023.2266935] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/13/2023] Open
Affiliation(s)
- Henri-Corto Stoeklé
- Department of Ethics and Scientific Integrity, Foch Hospital, Suresnes, France
| | - Sakina Sekkate
- Department of Oncology and Supportive Care, Supportive Care Center, Line Renaud Institute, Foch Hospital, Suresnes, France
| | - Jean-Marc Ayoubi
- Department of Reproductive Medicine, Gynecology and Obstetrics, Foch Hospital, Suresnes, France
- Medical School, Versailles Saint-Quentin-en-Yvelines University (UVSQ), Montigny-le-Bretonneux, France
| | - Jaafar Bennouna
- Department of Oncology and Supportive Care, Supportive Care Center, Line Renaud Institute, Foch Hospital, Suresnes, France
| | - Philippe Beuzeboc
- Department of Oncology and Supportive Care, Supportive Care Center, Line Renaud Institute, Foch Hospital, Suresnes, France
| | - Christian Hervé
- Department of Ethics and Scientific Integrity, Foch Hospital, Suresnes, France
- Medical School, Versailles Saint-Quentin-en-Yvelines University (UVSQ), Montigny-le-Bretonneux, France
- Medical School, Paris Cité University, Paris, France
| |
Collapse
|
6
|
Lavery S, Ayoubi JM, de Ziegler D. From rockstar doctors to bland brands: the changing face of assisted reproduction. Fertil Steril 2023; 120:955-956. [PMID: 37127130 DOI: 10.1016/j.fertnstert.2023.04.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Accepted: 04/22/2023] [Indexed: 05/03/2023]
Affiliation(s)
- Stuart Lavery
- Divisional Clinical Director Women's Health, University College Hospitals NHS Foundation Trust, London, United Kingdom
| | - Jean-Marc Ayoubi
- Department of Obstetrics and Gynecology and Reproductive Medicine, Hopital Foch, Paris, France
| | - Dominique de Ziegler
- Department of Obstetrics and Gynecology and Reproductive Medicine, Hopital Foch, Paris, France
| |
Collapse
|
7
|
Vallée A, Feki A, Ayoubi JM. Endometriosis in transgender men: recognizing the missing pieces. Front Med (Lausanne) 2023; 10:1266131. [PMID: 37720510 PMCID: PMC10501128 DOI: 10.3389/fmed.2023.1266131] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2023] [Accepted: 08/21/2023] [Indexed: 09/19/2023] Open
Abstract
Endometriosis, traditionally associated with cisgender women, should be recognized as a significant issue for transgender men. This perspective highlights the need to address the unique experiences and challenges faced by transgender men with endometriosis. Diagnostic difficulties arise due to hormone therapy and surgical interventions, which can alter symptoms. Limited research in transgender men undergoing hysterectomy further complicates the understanding of endometriosis in this population. Healthcare providers must be aware of these challenges and adapt the diagnostic approaches accordingly. Education and inclusive care are essential to ensure timely and appropriate management of endometriosis in transgender men, ultimately improving their quality of life.
Collapse
Affiliation(s)
- Alexandre Vallée
- Department of Epidemiology and Public Health, Foch Hospital, Suresnes, France
| | - Anis Feki
- Department of Gynecology and Obstetrics, University Hospital of Fribourg, Fribourg, Switzerland
| | - Jean-Marc Ayoubi
- Department of Obstetrics, Gynecology and Reproductive Medicine, Foch Hospital, Suresnes, France
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines (UVSQ), Versailles, France
| |
Collapse
|
8
|
Reitz L, Balaya V, Pache B, Feki A, Le Conte G, Benammar A, Ayoubi JM. Ovarian Follicular Response Is Altered by Salpingectomy in Assisted Reproductive Technology: A Pre- and Postoperative Case-Control Study. J Clin Med 2023; 12:4942. [PMID: 37568343 PMCID: PMC10419397 DOI: 10.3390/jcm12154942] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2023] [Revised: 07/20/2023] [Accepted: 07/20/2023] [Indexed: 08/13/2023] Open
Abstract
Objectives: The goal of this study was to assess the effect of unilateral salpingectomy on the number of mature follicles in the ipsilateral ovary during an assisted reproductive technology (ART) stimulation cycle, as compared to the contralateral ovary. Methods: This was a retrospective, single-center, case-control cohort study conducted from 2017 to 2022. Patients from 18 to 43 years old who underwent at least one ART cycle before and after a unilateral salpingectomy were included. The number of recruited follicles, including mature (≥16 mm) and intermediate follicles (13-15.5 mm), on the salpingectomy side (case) were compared to those present on the contralateral ovary (control) during an ART attempt. To take into account the inter-ovarian variability, the comparison was performed on two ART cycles, performed before then after the salpingectomy. Results: Overall, 24 patients were included in our study. While the number of mature follicles was similar in both ovaries before surgery, the mean number of mature follicles was significantly reduced after salpingectomy in the operated side, as compared to the control side, being, respectively 3.00 vs. 5.08 (p = 0.048). There was no significant difference between the intermediate and total recruited follicles. Conclusions: Our study suggests that salpingectomy may impact the follicle recruitment on the ipsilateral side by altering the vascularization during mesosalpinx coagulation. Gynecologists should be mindful of this concept and accurately set surgical indications. Beyond the indication, this emphasizes the critical role of having infertility surgeons sensitive to fertility preservation for optimal management of ART patients. Further studies with larger patient populations are required to confirm these results.
Collapse
Affiliation(s)
- Laurianne Reitz
- Obstetrics and Gynecology Department, Foch Hospital, 92150 Suresnes, France; (G.L.C.); (A.B.); (J.-M.A.)
- Gynecology and Obstetrics Unit, University Hospital of Reunion Island, BP 350, 97448 Saint Pierre Cedex, France
- Department of Obstetrics and Gynecology, Félix Guyon Hospital, CHU Nord of La Réunion, 97400 Saint-Denis, France;
| | - Vincent Balaya
- Department of Obstetrics and Gynecology, Félix Guyon Hospital, CHU Nord of La Réunion, 97400 Saint-Denis, France;
| | - Basile Pache
- Obstetrics and Gynecology Department, Fribourg Cantonal Hospital, 1708 Fribourg, Switzerland; (B.P.); (A.F.)
- Faculty of Medicine, University of Fribourg, 1700 Fribourg, Switzerland
| | - Anis Feki
- Obstetrics and Gynecology Department, Fribourg Cantonal Hospital, 1708 Fribourg, Switzerland; (B.P.); (A.F.)
- Faculty of Medicine, University of Fribourg, 1700 Fribourg, Switzerland
| | - Grégoire Le Conte
- Obstetrics and Gynecology Department, Foch Hospital, 92150 Suresnes, France; (G.L.C.); (A.B.); (J.-M.A.)
| | - Achraf Benammar
- Obstetrics and Gynecology Department, Foch Hospital, 92150 Suresnes, France; (G.L.C.); (A.B.); (J.-M.A.)
| | - Jean-Marc Ayoubi
- Obstetrics and Gynecology Department, Foch Hospital, 92150 Suresnes, France; (G.L.C.); (A.B.); (J.-M.A.)
- Medical School, University of Versailles Saint-Quentin, 78000 Versailles, France
| |
Collapse
|
9
|
Benammar A, Munnich A, Poulain M, Magnan F, Racowsky C, Ayoubi JM. The importance of on-site genetic counseling for prospective assisted reproductive technology patients. J Assist Reprod Genet 2023:10.1007/s10815-023-02802-2. [PMID: 37310663 DOI: 10.1007/s10815-023-02802-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2023] [Accepted: 04/11/2023] [Indexed: 06/14/2023] Open
Abstract
PURPOSE To assess the value of having an onsite genetic counseling service integrated into an assisted reproductive technology (ART) center. METHODS Since January 2021, we have offered genetic counseling at our ART center for couples whose medical history suggests risk of transmission of a genetic disorder. The percentage of couples referred for genetic counseling, the distribution of couples according to reasons for consultation, the mode of transmission in cases of Mendelian disorders, and the frequency of mutations for those with identified genetic disorders were determined. RESULTS In an 18-month period, 150 of 1340 couples (11.2%) enrolled for ART treatment were referred to the genetic counseling unit. Two-thirds (99/150, 66.0%) were referred for a known genetic risk, a family history of a genetic disorder or chromosomal abnormality, a serious condition of unknown cause, or consanguinity. The remaining couples had a putative genetic risk (diminished ovarian reserve, high incidence of oocyte immaturity, recurrent abortion, or severe male infertility). Of the 99 with known genetic risk, 62 (62.7%), were approved for ART treatment, 23 (23.2%) were recommended prenatal or preimplantation testing, and 14 (14.1%) were referred for further testing before undergoing ART. CONCLUSIONS Our findings reveal great value in having an on-site genetic counseling unit for referral of ART patients. Such a unit makes the ART process smoother and safer for couples, and it lightens the burden of ART staff by removing responsibilities for which they are neither trained, nor should they have to assume.
Collapse
Affiliation(s)
- Achraf Benammar
- Department of Obstetrics, Gynecology and Reproductive Medicine, Foch Hospital, 40 Rue Worth, 92151, Suresnes, France.
| | - Arnold Munnich
- Department of Obstetrics, Gynecology and Reproductive Medicine, Foch Hospital, 40 Rue Worth, 92151, Suresnes, France
- INSERM, Paris, Île-de-France, France
| | - Marine Poulain
- Department of Obstetrics, Gynecology and Reproductive Medicine, Foch Hospital, 40 Rue Worth, 92151, Suresnes, France
- Université Paris-Saclay, University of Versailles, INRAE, ENVA, Jouy-en-Josas, BREED, France
| | - Fanny Magnan
- Department of Obstetrics, Gynecology and Reproductive Medicine, Foch Hospital, 40 Rue Worth, 92151, Suresnes, France
| | - Catherine Racowsky
- Department of Obstetrics, Gynecology and Reproductive Medicine, Foch Hospital, 40 Rue Worth, 92151, Suresnes, France
| | - Jean-Marc Ayoubi
- Department of Obstetrics, Gynecology and Reproductive Medicine, Foch Hospital, 40 Rue Worth, 92151, Suresnes, France
- Université Paris-Saclay, University of Versailles, INRAE, ENVA, Jouy-en-Josas, BREED, France
| |
Collapse
|
10
|
Affiliation(s)
- Paul Pirtea
- Correspondence address. Hospital Foch, 40 Rue Worth, 92150 Suresnes, France. E-mail:
| | | | | | - Richard Scott
- Reproductive Medicine Associates of New Jersey, Basking Ridge, NJ, USA
| | | |
Collapse
|
11
|
Carbonnel M, Ayoubi JM. [Uterine transplantation: a treatment for absolute uterine infertility]. Rev Prat 2023; 73:471-476. [PMID: 37309778] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/14/2023]
Abstract
UTERINE TRANSPLANTATION A TREATMENT FOR ABSOLUTE UTERINE INFERTILITY. Uterine transplantation (UT) is the first proposed treatment for absolute uterine infertility. It is also the first organ transplant of a transitory nature performed for a non-vital indication: the ability to carry a child and give birth. Today, with about one hundred transplants performed worldwide, uterine transplantation is at the crossroads between the experimental phase and current practice. The first uterine transplant was performed in France in 2019 at the Foch Hospital (Suresnes). It allowed the birth of two healthy little girls in 2021 and 2023. The second transplant was performed in September 2022. A state of the art allows to review the steps necessary for a successful transplantation from donor and recipient selection to surgery, immunosuppressive treatment and pregnancies. Potential future developments could make it possible to simplify this complex surgery, which is not without raising ethical questions.
Collapse
Affiliation(s)
- Marie Carbonnel
- Service de gynécologieobstétrique et médecine de la reproduction, hôpital Foch, Suresnes ; UFR Simone-Veil, université de Versailles, Saint-Quentinen- Yvelines
| | - Jean-Marc Ayoubi
- Service de gynécologieobstétrique et médecine de la reproduction, hôpital Foch, Suresnes ; UFR Simone-Veil, université de Versailles, Saint-Quentinen- Yvelines
| |
Collapse
|
12
|
Carbonnel M, Legendri S, Trabelsi H, Aubry G, Ayoubi JM. [Endometriosis]. Rev Prat 2023; 73:209-215. [PMID: 36916266] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 03/16/2023]
Affiliation(s)
- Marie Carbonnel
- Service de gynécologie-obstétriquue de l'hôpital Foch, Suuresnes, France
| | - Sophie Legendri
- Service de gynécologie-obstétriquue de l'hôpital Foch, Suuresnes, France
| | - Hanen Trabelsi
- Service de radiologie de l'hôpital Foch, Suresnes, France
| | - Gabrielle Aubry
- Service de gynécologie-obstétriquue de l'hôpital Foch, Suuresnes, France
| | - Jean-Marc Ayoubi
- Service de gynécologie-obstétriquue de l'hôpital Foch, Suuresnes, France
| |
Collapse
|
13
|
Vallée A, Chatelain A, Carbonnel M, Racowsky C, Fourn E, Zucman D, Ayoubi JM. Monkeypox Virus Infection in 18-Year-Old Woman after Sexual Intercourse, France, September 2022. Emerg Infect Dis 2023; 29:219-222. [PMID: 36355630 PMCID: PMC9796185 DOI: 10.3201/eid2901.221643] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022] Open
Abstract
A monkeypox virus outbreak has spread worldwide since April 2022. We report a young woman in France positive for monkeypox virus transmitted through oral and vaginal sex. Ulceronecrotic lesions developed intravaginally and around her vulva. Health professionals should become familiar with all aspects of infection from this virus, including possible vertical transmission.
Collapse
|
14
|
Guani B, Balaya V, Ayoubi JM, Feki A, Lecuru FR, Mathevet P. Laparoscopic vaginal radical trachelectomy in the post-LACC era: step-by-step surgical procedure. Int J Gynecol Cancer 2022; 32:1617-1618. [PMID: 36270771 DOI: 10.1136/ijgc-2022-003462] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Affiliation(s)
- Benedetta Guani
- Department of Gynecology and Obstetrics, HFR, Fribourg, Switzerland .,Departement de Gynecologie-obstetrique et Genetique Medicale, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.,Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
| | - V Balaya
- Department of Gynecology, Foch Hospital, Suresnes, France
| | - J M Ayoubi
- Department of Gynecology, Foch Hospital, Suresnes, France
| | - Anis Feki
- Department of Gynecology and Obstetrics, HFR, Fribourg, Switzerland.,Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland
| | - Fabrice R Lecuru
- Breast, Gynecology and Reconstructive Surgery Unit, Institute Curie, Paris, France
| | - Patrice Mathevet
- Departement de Gynecologie-obstetrique et Genetique Medicale, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.,Faculty of Biology and Medicine, University of Lausanne, UNIL, Lausanne, Switzerland
| |
Collapse
|
15
|
Fruscalzo A, Carbonnel M, Pirtea P, Poulain M, Guani B, de Joliniere JB, Ayoubi JM, Feki A. Editorial: Practical impact of the newest achievements in assisted reproductive technologies (ART). Front Med (Lausanne) 2022; 9:1086972. [DOI: 10.3389/fmed.2022.1086972] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Accepted: 11/14/2022] [Indexed: 11/29/2022] Open
|
16
|
Legendri S, Carbonnel M, Feki A, Moawad G, Aubry G, Vallée A, Ayoubi JM. Improvement of Post-Operative Quality of Life in Patients 2 Years after Minimally Invasive Surgery for Pain and Deep Infiltrating Endometriosis. J Clin Med 2022; 11:jcm11206132. [PMID: 36294462 PMCID: PMC9605320 DOI: 10.3390/jcm11206132] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2022] [Revised: 10/04/2022] [Accepted: 10/13/2022] [Indexed: 11/18/2022] Open
Abstract
This study addressed the improvement in the quality of life of patients 2 years after minimally invasive surgery for painful deep infiltrating endometriosis (DIE), evaluated with EHP-5 (Endometriosis Health Profile-5) scores and the intensity of dysmenorrhea and dyspareunia. This was a retrospective study, performed in a referral centre for endometriosis, between January 2010 and January 2019. EHP-5 scores were complete for 54 patients, and two subgroups were analysed: classic laparoscopy (CL) vs. robotic laparoscopy (RL), and conservative surgery (ConservS) vs. total surgery (TS). There was an important decrease in 2-year post-operative EHP-5 scores in the global population (pre-op: 61.36 (42.18−68.75) and 2-year post-op: 20.45 (0−38.06); p < 0.001). The Visual Analogic Scale (VAS) was also lower for dysmenorrhea (pre-op: 8 (7−9.75) vs. 2-year post-op: 3 (2−5.25); p < 0.001) and dyspareunia (pre-op: 6 (3.1−8.9) vs. 2-year post-op: 3 (0−6); p < 0.001). In the subgroup analysis, EHP-5 scores were improved in the RL group (pre-op: 65.9 (59.09−71.02) vs. 2-year post-op: 11.4 (0−38.06); p < 0.001) and the CL group (pre-op: 50 (34.65−68.18) vs. 2-year post-op: 27.27 (14.20−40.90); p < 0.001), with a slight advantage for RL (p = 0.04), and the same improvements were found for ConservS (pre-op: 61.4 (38.06−71.59) vs. 2-year post-op: 22.7 (11.93−38.07); p < 0.001) and TS groups (pre-op: 61.59 (51.70−68.75) vs. 2-year post-op: 13.63 (0−44.30); p < 0.001). Minimally invasive surgery improved the quality of life for DIE patients 2 years after surgery, and conservative surgery showed comparable results to total surgery.
Collapse
Affiliation(s)
- Sophie Legendri
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines, 55 Avenue de Paris, 78000 Versailles, France
| | - Marie Carbonnel
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines, 55 Avenue de Paris, 78000 Versailles, France
- Correspondence:
| | - Anis Feki
- Department of Obstetrics and Gynecology, Cantonal Hospital Fribourg, 1702 Fribourg, Switzerland
| | - Gaby Moawad
- Department of Obstetrics and Gynecology, The George Washington University Hospital, Washington, DC 20037, USA
| | - Gabrielle Aubry
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
| | - Alexandre Vallée
- Department of Clinical Research and Innovation, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
| | - Jean-Marc Ayoubi
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines, 55 Avenue de Paris, 78000 Versailles, France
| |
Collapse
|
17
|
Carbonnel M, Karpel L, Corruble N, Legendri S, Pencole L, Cordier B, Racowsky C, Ayoubi JM. Transgender Males as Potential Donors for Uterus Transplantation: A Survey. J Clin Med 2022; 11:jcm11206081. [PMID: 36294400 PMCID: PMC9605112 DOI: 10.3390/jcm11206081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2022] [Revised: 09/25/2022] [Accepted: 10/11/2022] [Indexed: 11/16/2022] Open
Abstract
Uterus transplantation is a new treatment for patients with absolute uterine infertility that is conducted in order to enable them to carry their own pregnancy. One of the limitations for its development is donor availability. Some transgender males undergo a hysterectomy in the gender-affirming surgery process, and might be interested in donating their uterus for transplantation. In this manuscript, we report the results of a survey designed to determine the attitudes of such individuals regarding donation of their uterus for this purpose. Over 32 years (January 1989-January 2021), 348 biological women underwent hysterectomy at our hospital as part of gender-affirming surgery. The survey was sent to 212 of the 348 prospective participants (for 136, we lacked postal or email addresses). Among the 212 surveys sent, we obtained responses from 94 individuals (44%): 83 (88.3%) stated they would agree to donate, of whom 44 would do so for altruism, 23 for the usefulness of the gesture and 16 out of understanding of the desire to have a child; 63 (75.5%) wanted to know the recipient and 45 (54.2%) wanted to know the result of the donation. According to this survey, a high proportion of transgender males surveyed would be interested in donating their uterus for uterus transplantation.
Collapse
Affiliation(s)
- Marie Carbonnel
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines, 55 Avenue de Paris, 78000 Versailles, France
- Correspondence:
| | - Léa Karpel
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
| | - Ninon Corruble
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
| | - Sophie Legendri
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
| | - Lucile Pencole
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
| | - Bernard Cordier
- Department of Psychiatry, Hospital Foch, 40 Rue Worth, 92150 Suresnes, France
| | - Catherine Racowsky
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
- Department of Psychiatry, Hospital Foch, 40 Rue Worth, 92150 Suresnes, France
- Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Boston, MA 02115, USA
| | - Jean-Marc Ayoubi
- Department of Obstetrics and Gynecology, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines, 55 Avenue de Paris, 78000 Versailles, France
| |
Collapse
|
18
|
Fruscalzo A, Dayer A, Londero AP, Guani B, Khomsi F, Ayoubi JM, Feki A. Endometriosis and Infertility: Prognostic Value of #Enzian Classification Compared to rASRM and EFI Score. J Pers Med 2022; 12:jpm12101623. [PMID: 36294762 PMCID: PMC9605607 DOI: 10.3390/jpm12101623] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2022] [Revised: 09/17/2022] [Accepted: 09/22/2022] [Indexed: 11/16/2022] Open
Abstract
This study’s objective was to compare the predictive validity of the three most utilized classification scores for endometriosis, #Enzian, EFI, and rASRM, in achieving a spontaneous pregnancy or pregnancy via assisted reproductive technology (ART) after surgery for endometriosis. The monocentric retrospective study was carried out from January 2012 to December 2021 at the gynaecology department of the cantonal hospital of Fribourg. Patients consulting for infertility and operated on for endometriosis with histological confirmation were included. The predictive value of #Enzian, rASRM, and EFI was evaluated and compared concerning the prediction of fertility after surgery, both spontaneous and ART, during the following 12 months. A total of 58 women (mean age 33.1 ± 4.57 years) were included. Overall, 30 women achieved a pregnancy, seven spontaneously. Among all women who achieved a pregnancy, there was a lower prevalence of rASRM stage III−IV (16.67% vs. 39.29%, p = 0.054). Women achieving a pregnancy had a significantly higher EFI score than others (p < 0.05). No significant differences were observed concerning the #Enzian score. In conclusion, the revised #Enzian score is not correlated with pregnancy achievement; EFI score is the only score significantly associated with the pregnancy outcome in women affected by endometriosis.
Collapse
Affiliation(s)
- Arrigo Fruscalzo
- Clinic of Obstetrics and Gynaecologz, HFR—Hòpital Fribourgeois, Chemin des Pensionnats 2-6, 1708 Fribourg, Switzerland
- Faculty of Medicine, University of Münster, Domagkstraße 3, 48149 Münster, Germany
- Correspondence:
| | - Arnaud Dayer
- Clinic of Obstetrics and Gynaecologz, HFR—Hòpital Fribourgeois, Chemin des Pensionnats 2-6, 1708 Fribourg, Switzerland
| | - Ambrogio Pietro Londero
- Academic Unit of Obstetrics and Gynaecology, Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Infant Health, University of Genova, 16132 Genova, Italy or
- Ennergi Research (Non-Profit Organization), 33050 Lestizza, Italy
| | - Benedetta Guani
- Clinic of Obstetrics and Gynaecologz, HFR—Hòpital Fribourgeois, Chemin des Pensionnats 2-6, 1708 Fribourg, Switzerland
| | - Fathi Khomsi
- Clinic of Obstetrics and Gynaecologz, HFR—Hòpital Fribourgeois, Chemin des Pensionnats 2-6, 1708 Fribourg, Switzerland
| | - Jean-Marc Ayoubi
- Department of Obstetrics and Gynecology and Reproductive Medicine, Hopital Foch–Faculté de Médecine Paris, 92150 Suresnes, France
| | - Anis Feki
- Clinic of Obstetrics and Gynaecologz, HFR—Hòpital Fribourgeois, Chemin des Pensionnats 2-6, 1708 Fribourg, Switzerland
| |
Collapse
|
19
|
Le Gal C, Carbonnel M, Balaya V, Richard C, Gelin V, Galio L, Sandra O, Hersant B, Bosc R, Charton J, Chavatte-Palmer P, Vialard F, Coscas R, Ayoubi JM. Analysis of Predictive Factors for Successful Vascular Anastomoses in a Sheep Uterine Transplantation Model. J Clin Med 2022; 11:jcm11185262. [PMID: 36142908 PMCID: PMC9503062 DOI: 10.3390/jcm11185262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/20/2022] [Revised: 07/27/2022] [Accepted: 09/02/2022] [Indexed: 11/16/2022] Open
Abstract
Uterine transplantation is becoming an increasingly realistic therapeutic for uterine infertility. Surgical training on large animal models such as sheep is a prerequisite for establishing a program in humans. The objective of our study was to analyze the predictive factors for successful vascular anastomoses. We performed 40 autotransplants that involved end-to-side anastomoses from the uterine to the external iliac vessels. We analyzed vessel results in terms of success or failure; a total of 78.7% of arterial and 82.9% of venous anastomoses were successful in the immediate postoperative period. In multivariate analysis, independent factors associated with immediate successful vein anastomoses were as follows: a short warm ischemia time (<2 h, OR = 0.05; 95% CI [0.003−0.88], p = 0.04), the absence of any anastomotic complications (OR = 0.06; 95% CI [0.003−0.099], p = 0.049), and their realization by a vascular surgeon (OR = 29.3; 95% CI [1.17−731.9], p = 0.04). Secondly, we showed that an increase in lactate levels greater than 2.72 mmol/L, six hours after reperfusion was predictive of failure, with a sensibility of 85.7% and a specificity of 75.0%. In order to perfect the management of vascular anastomoses by a vascular surgeon, training on animal models and in microsurgery are mandatory in establishing a uterine transplantation program in humans.
Collapse
Affiliation(s)
- Claire Le Gal
- UVSQ, INRAE, BREED, Paris-Saclay University, 78350 Jouy-en-Josas, France
| | - Marie Carbonnel
- UVSQ, INRAE, BREED, Paris-Saclay University, 78350 Jouy-en-Josas, France
- Department of Gynecology and Obstetrics, Foch Hospital, 92150 Suresnes, France
- Correspondence:
| | - Vincent Balaya
- Department of Gynecology and Obstetrics, Foch Hospital, 92150 Suresnes, France
| | - Christophe Richard
- UVSQ, INRAE, BREED, Paris-Saclay University, 78350 Jouy-en-Josas, France
- National Veterinary School, BREED, 94700 Maisons-Alfort, France
- MIMA2 Platform, INRAE, 78350 Jouy-en-Josas, France
| | - Valerie Gelin
- UVSQ, INRAE, BREED, Paris-Saclay University, 78350 Jouy-en-Josas, France
- National Veterinary School, BREED, 94700 Maisons-Alfort, France
- MIMA2 Platform, INRAE, 78350 Jouy-en-Josas, France
| | - Laurent Galio
- UVSQ, INRAE, BREED, Paris-Saclay University, 78350 Jouy-en-Josas, France
- National Veterinary School, BREED, 94700 Maisons-Alfort, France
| | - Olivier Sandra
- UVSQ, INRAE, BREED, Paris-Saclay University, 78350 Jouy-en-Josas, France
- National Veterinary School, BREED, 94700 Maisons-Alfort, France
| | - Barbara Hersant
- Department of Maxillofacial and Plastic & Reconstructive Surgery, Henri Mondor University Hospital, 94000 Creteil, France
| | - Romain Bosc
- Department of Maxillofacial and Plastic & Reconstructive Surgery, Henri Mondor University Hospital, 94000 Creteil, France
| | - Johanna Charton
- Department of Vascular Surgery, Amboise Pare University Hospital, AP-HP, 92100 Boulogne-Billancourt, France
| | - Pascale Chavatte-Palmer
- UVSQ, INRAE, BREED, Paris-Saclay University, 78350 Jouy-en-Josas, France
- National Veterinary School, BREED, 94700 Maisons-Alfort, France
| | - François Vialard
- UVSQ, INRAE, BREED, Paris-Saclay University, 78350 Jouy-en-Josas, France
- National Veterinary School, BREED, 94700 Maisons-Alfort, France
- Department of Genetics, Medical Biology Laboratory, Poissy-St Germain en Laye University Hospital, 78300 Poissy, France
| | - Raphael Coscas
- Department of Vascular Surgery, Amboise Pare University Hospital, AP-HP, 92100 Boulogne-Billancourt, France
- UMR 1018, Inserm-Paris11-CESP, Versailles Saint-Quentin-en-Yvelines University, 78000 Versailles, France
| | - Jean-Marc Ayoubi
- UVSQ, INRAE, BREED, Paris-Saclay University, 78350 Jouy-en-Josas, France
- Department of Gynecology and Obstetrics, Foch Hospital, 92150 Suresnes, France
| |
Collapse
|
20
|
Pirtea P, de Ziegler D, Ayoubi JM. Uterine infertility, the last frontier. Fertil Steril 2022; 118:463-464. [PMID: 35931492 DOI: 10.1016/j.fertnstert.2022.06.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2022] [Accepted: 06/28/2022] [Indexed: 01/13/2023]
Affiliation(s)
- Paul Pirtea
- Department of Obstetrics, Gynecology, and Reproductive Medicine, Hospital Foch - Faculté de Médecine Paris Ouest (UVSQ), Suresnes, France
| | - Dominique de Ziegler
- Department of Obstetrics, Gynecology, and Reproductive Medicine, Hospital Foch - Faculté de Médecine Paris Ouest (UVSQ), Suresnes, France
| | - Jean-Marc Ayoubi
- Department of Obstetrics, Gynecology, and Reproductive Medicine, Hospital Foch - Faculté de Médecine Paris Ouest (UVSQ), Suresnes, France
| |
Collapse
|
21
|
Carbonnel M, Daclin C, Tourne M, Roux E, Le-Marchand M, Racowsky C, Kennel T, Farfour E, Vasse M, Ayoubi JM. Impact of COVID-19 on Subclinical Placental Thrombosis and Maternal Thrombotic Factors. J Clin Med 2022; 11:jcm11144067. [PMID: 35887831 PMCID: PMC9323982 DOI: 10.3390/jcm11144067] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2022] [Revised: 07/04/2022] [Accepted: 07/09/2022] [Indexed: 02/04/2023] Open
Abstract
Background: In the context of the SARS-CoV-2 pandemic, our interest was to evaluate the effect of COVID-19 during pregnancy on placenta and coagulation factors. Methods: a prospective cohort study between January and July 2021 of 55 pregnant women stratified into: Group O, 16 patients with ongoing SARS-CoV-2 infection at delivery; Group R, 21 patients with a history of SARS-CoV-2 infection during pregnancy but who recovered prior to delivery; Group C, 18 control patients with no infection at any time. All women had nasopharyngeal SARS-CoV-2 RT-PCR tests performed within 72 h of delivery. Obstetrical complications were recorded and two physiological inhibitors of coagulation, protein Z (PZ) and dependent protease inhibitor (ZPI), were analyzed in maternal and cord blood. All placentae were analyzed by a pathologist for vascular malperfusion. Results: No patient in any group had a severe COVID-19 infection. More obstetrical complications were observed in Group O (O: n = 6/16 (37%), R: n = 2/21 (10%), C: n = 1/18 (6%), p = 0.03). The incidence of placental vascular malperfusion was similar among the groups (O: n = 9/16 (56%), R: n = 8/21 (42%), C: n = 8/18 (44%), p = 0.68). No PZ or ZPI deficiency was associated with COVID-19. However, an increased ZPI/PZ ratio was observed in neonates of Group R (O: 82.6 (min 41.3–max 743.6), R: 120.7 (29.8–203.5), C: 66.8 (28.2–2043.5), p = 0.04). Conclusion: COVID-19 was associated with more obstetrical complications, but not an increased incidence of placental lesions or PZ and ZPI abnormalities.
Collapse
Affiliation(s)
- Marie Carbonnel
- Department of Obstetrics and Gynecology, Hospital Foch, 40, Rue Worth, 92150 Suresnes, France; (C.D.); (C.R.); (J.-M.A.)
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines, 55, Avenue de Paris, 78000 Versailles, France;
- Correspondence:
| | - Camille Daclin
- Department of Obstetrics and Gynecology, Hospital Foch, 40, Rue Worth, 92150 Suresnes, France; (C.D.); (C.R.); (J.-M.A.)
| | - Morgan Tourne
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines, 55, Avenue de Paris, 78000 Versailles, France;
- Department of Pathology, Hospital Foch, Hospital Foch, 40, Rue Worth, 92150 Suresnes, France
| | - Emmanuel Roux
- Department of Clinic Research, Hospital Foch, 40, Rue Worth, 92150 Suresnes, France; (E.R.); (M.L.-M.); (T.K.)
| | - Mathilde Le-Marchand
- Department of Clinic Research, Hospital Foch, 40, Rue Worth, 92150 Suresnes, France; (E.R.); (M.L.-M.); (T.K.)
| | - Catherine Racowsky
- Department of Obstetrics and Gynecology, Hospital Foch, 40, Rue Worth, 92150 Suresnes, France; (C.D.); (C.R.); (J.-M.A.)
- Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women’s Hospital, Boston, MA 02115, USA
| | - Titouan Kennel
- Department of Clinic Research, Hospital Foch, 40, Rue Worth, 92150 Suresnes, France; (E.R.); (M.L.-M.); (T.K.)
| | - Eric Farfour
- Department of Clinical Biology, Hospital Foch, 40, Rue Worth, 92150 Suresnes, France; (E.F.); (M.V.)
| | - Marc Vasse
- Department of Clinical Biology, Hospital Foch, 40, Rue Worth, 92150 Suresnes, France; (E.F.); (M.V.)
- UMR-S 1176, Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, 94270 Le Kremlin-Bicêtre, France
| | - Jean-Marc Ayoubi
- Department of Obstetrics and Gynecology, Hospital Foch, 40, Rue Worth, 92150 Suresnes, France; (C.D.); (C.R.); (J.-M.A.)
- Medical School, University of Versailles, Saint-Quentin-en-Yvelines, 55, Avenue de Paris, 78000 Versailles, France;
| |
Collapse
|
22
|
Affiliation(s)
- Henri-Corto Stoeklé
- Department of Ethics and Scientific Integrity, Foch Hospital, Suresnes, France
| | - Sakina Sekkate
- Oncology and Supportive Care Department, Foch Hospital, Suresnes, France
| | - Jean-Marc Ayoubi
- Department of Obstetrics, Gynecology and Reproductive Medicine, Hôpital Foch, Faculté de Médecine Paris Ouest (UVSQ), Suresnes, France
| | - Philippe Beuzeboc
- Oncology and Supportive Care Department, Foch Hospital, Suresnes, France
| | - Christian Hervé
- Department of Ethics and Scientific Integrity, Foch Hospital, Suresnes, France.,Medical School, University of Paris, Paris, France.,Medical School, Versailles-Saint-Quentin-en-Yvelines University, Montigny le Bretonneux, France.,International Academy of Medical Ethics and Public Health, University of Paris, Paris, France.,Veterinary Academy of France, Paris, France
| |
Collapse
|
23
|
Chamagne M, Naoura I, Abbou H, Le Conte G, Ayoubi JM. [Diaphragmatic ruptur during labour: A case report]. Gynecol Obstet Fertil Senol 2022; 50:338-339. [PMID: 34954403 DOI: 10.1016/j.gofs.2021.12.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/04/2021] [Revised: 12/16/2021] [Accepted: 12/16/2021] [Indexed: 06/14/2023]
Affiliation(s)
- M Chamagne
- Département de gynécologie obstétrique, hôpital Foch, 40, rue Worth, 92150 Suresnes, France.
| | - I Naoura
- Département de gynécologie obstétrique, hôpital Foch, 40, rue Worth, 92150 Suresnes, France
| | - H Abbou
- Département de gynécologie obstétrique, hôpital Foch, 40, rue Worth, 92150 Suresnes, France
| | - G Le Conte
- Département de gynécologie obstétrique, hôpital Foch, 40, rue Worth, 92150 Suresnes, France
| | - J M Ayoubi
- Département de gynécologie obstétrique, hôpital Foch, 40, rue Worth, 92150 Suresnes, France
| |
Collapse
|
24
|
Daclin C, Carbonnel M, Rossignol M, Abbou H, Trabelsi H, Cimmino A, Delmas J, Rifai AS, Coiquaud LA, Tiberon A, Guen ML, Ayoubi JM. Impact of COVID-19 infection in pregnancy and neonates: a case control study. J Gynecol Obstet Hum Reprod 2022; 51:102366. [PMID: 35346897 PMCID: PMC8949840 DOI: 10.1016/j.jogoh.2022.102366] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Revised: 03/15/2022] [Accepted: 03/23/2022] [Indexed: 11/05/2022]
Abstract
Objective To evaluate maternal and neonatal outcomes of pregnant women who were infected by COVID-19 during pregnancy. Study design A Case control retrospective study was conducted in an Obstetrical Department of a west Parisian area during the first year of COVID-19 pandemic. Maternal and neonatal outcomes were compared between a group of women infected by the SARS-CoV-2 virus during pregnancy (March 2020- February 2021) and a control group of women delivering before pandemic. They were matched according to age and parity. Subgroups of SARS-CoV-2 infection occurring before vs after 37 weeks of gestations and symptomatic vs asymptomatic patients were analyzed. The rate of preterm birth, preeclampsia, placental abruption and stillbirth were compared between the year of pandemic and the year before for all deliveries. Results Maternal and neonatal outcomes were similar. Among the 86 pregnant women with SARS-CoV-2 infection, five were admitted to Hospital (5.8%). One was transferred in intensive care unit for respiratory distress (1.2%). All patients had favorable outcomes. Patients with symptoms had more associated comorbidities (34.5%, n = 20/58, with symptoms, vs 9,1%, n = 2/22, without symptoms, p = 0.023). No differences in preeclampsia, placenta abruption and stillbirth, but less preterm births (4.9%, n = 160/3383 vs 6.2%, n = 209/3235, p = 0.04) were observed between the year of pandemic and the year before. Conclusion There were few complications associated with COVID-19 infection among pregnant patients and their neonates. A low rate of associated comorbidities, a good access to healthcare services in this area and the small sample size of patients could explain these results.
Collapse
|
25
|
Favre-Inhofer A, Carbonnel M, Domert J, Cornet N, Chastant S, Coscas R, Vialard F, Gelin V, Galio L, Richard C, Trabelsi H, Sandra O, de Ziegler D, Chavatte-Palmer P, Ayoubi JM. Involving Animal Models in Uterine Transplantation. Front Surg 2022; 9:830826. [PMID: 35284480 PMCID: PMC8904568 DOI: 10.3389/fsurg.2022.830826] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2021] [Accepted: 01/24/2022] [Indexed: 01/15/2023] Open
Abstract
Background Absolute uterine factor infertility affects 0. 2% women of childbearing age around the world. Uterine transplantation (UTx) is a promising solution for many of them since the first birth from UTx was described by the Swedish team in 2014. The success of Utx in humans has become possible after a systematic and meticulous approach involving years of research on animal models. To date, more than 80 UTx procedures have been performed worldwide and 30 children were born. Material and Method This review summarizes the research preparation conducted in animals before beginning UTx in humans. It focuses on the advantages and limits of each animal model, their place in surgical training, and current contribution in research to improve UTx successes in humans. The different steps in the process of UTx have been analyzed, such as imaging, surgery, ischemia-reperfusion effects, rejection markers, immunosuppressive treatment, and pregnancy. Conclusion Animal models have played an essential role in the implementation of UTx, which is a highly complex procedure. While respecting the 3R requirements (replacement, refinement, and reduction), the surgical training using large animal models, such as notably ewes remain irreplaceable for teams wishing to initiate a UTx program. Furthermore, animal models are still mandatory in current research to improve the success rates of UTx in humans as well as to reduce the morbidity associated with this experimental infertility treatment.
Collapse
Affiliation(s)
- Angeline Favre-Inhofer
- Department of Gynaecology and Obstetrics, Foch Hospital, Suresnes, France
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- *Correspondence: Angeline Favre-Inhofer
| | - Marie Carbonnel
- Department of Gynaecology and Obstetrics, Foch Hospital, Suresnes, France
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
| | | | - Nathalie Cornet
- Department of Gynaecology and Obstetrics, Foch Hospital, Suresnes, France
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
| | | | - Raphaël Coscas
- Department of Vascular Surgery, Ambroise Paré University Hospital, AP-HP, Boulogne-Billancourt, France
- UMR 1018, Inserm-Paris11 - CESP, Versailles Saint-Quentin-en-Yvelines University, Paris-Saclay University, Boulogne-Billancourt, France
| | - François Vialard
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- École Nationale Vétérinaire d'Alfort, BREED, Maisons-Alfort, France
- Département de Génétique, Laboratoire de Biologie Médicale, CHI de Poissy-St Germain en Laye, Poissy, France
| | - Valérie Gelin
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- École Nationale Vétérinaire d'Alfort, BREED, Maisons-Alfort, France
| | - Laurent Galio
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- École Nationale Vétérinaire d'Alfort, BREED, Maisons-Alfort, France
| | - Christophe Richard
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- École Nationale Vétérinaire d'Alfort, BREED, Maisons-Alfort, France
| | - Héla Trabelsi
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- École Nationale Vétérinaire d'Alfort, BREED, Maisons-Alfort, France
| | - Olivier Sandra
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- École Nationale Vétérinaire d'Alfort, BREED, Maisons-Alfort, France
| | - Dominique de Ziegler
- Department of Gynaecology and Obstetrics, Foch Hospital, Suresnes, France
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
| | - Pascale Chavatte-Palmer
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- École Nationale Vétérinaire d'Alfort, BREED, Maisons-Alfort, France
| | - Jean-Marc Ayoubi
- Department of Gynaecology and Obstetrics, Foch Hospital, Suresnes, France
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
| |
Collapse
|
26
|
Vandame J, Fossard C, Filali M, Benammar A, Ranga S, Pirtea P, Racowsky C, Ayoubi JM, Poulain M. Investigation of the Reliability of Semi-Automatic Annotation by the Geri Time Lapse System. Reprod Biomed Online 2022; 45:35-45. [DOI: 10.1016/j.rbmo.2022.02.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2021] [Revised: 01/30/2022] [Accepted: 02/15/2022] [Indexed: 11/16/2022]
|
27
|
de Ziegler D, Pirtea P, Ayoubi JM. Outlining the practical options for coping with the shortcomings of vaginal progesterone recently unveiled in frozen embryo transfers: a story drafted in Turkey. Fertil Steril 2021; 117:38-39. [PMID: 34809977 DOI: 10.1016/j.fertnstert.2021.08.048] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2021] [Accepted: 08/31/2021] [Indexed: 11/04/2022]
Affiliation(s)
- Dominique de Ziegler
- Deptartment of Obstetrics and Gynecology and Reproductive Medicine, Hopital Foch - Faculté de Médecine Paris Ouest (UVSQ), Suresnes, France
| | - Paul Pirtea
- Deptartment of Obstetrics and Gynecology and Reproductive Medicine, Hopital Foch - Faculté de Médecine Paris Ouest (UVSQ), Suresnes, France
| | - Jean-Marc Ayoubi
- Deptartment of Obstetrics and Gynecology and Reproductive Medicine, Hopital Foch - Faculté de Médecine Paris Ouest (UVSQ), Suresnes, France
| |
Collapse
|
28
|
Fossard C, Farfour E, Benammar A, Filali M, Vandame J, Pirtea P, Steinberger F, Ranga S, Clemenceau M, Burguion M, Vasse M, Ayoubi JM, Poulain M. P–793 Validation of French in vitro fertilization (IVF) guideline during Covid–19 pandemic by the research of Sars-Cov–2 RNA in the follicular fluid (FF) after egg retrieval. Hum Reprod 2021. [DOI: 10.1093/humrep/deab130.792] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Study question
Is it possible to find viral Sars-Cov–2 RNA in FF of women undergoing treatment during Covid–19 pandemic that may compromise gamete and embryo safety?
Summary answer
No viral RNA was detected in tested FF of women undergoing IVF in compliance with recommendations. This was reassuring and supported good medical practice.
What is known already
Risks due to SARS-CoV–2 during IVF remain difficult to assess despite the screening recommended by French health authorities based on a symptom questionnaire of the couple (systematic testing by RT-PCR for the virus before egg retrieval (ER) is not mandatory). In this context, this is a real challenge for IVF laboratory to guarantee procedure, patients, gametes and embryos safety. Most studies have reported the absence of virus in sperm. No data are available for FF and only one study looked for the presence of the virus in oocytes of Covid-affected patients (Barragan M et al, 2020).
Study design, size, duration
Between June 17 and September 24, 2020, FF of consenting women were prospectively collected and symptom questionnaire recorded. During this period, women undergoing IVF in our center did not benefit from systematic PCR testing for the virus within 72 hours prior to ER through our health authorities’ recommendations. All collected FF were retrospectively tested to research viral RNA by RT-PCR and patients were recalled to answer an epidemiological follow-up questionnaire.
Participants/materials, setting, methods
For all couples, symptom questionnaires were prospectively recorded and verified at each step of IVF procedure. For all consenting women, a sample of 1 ml of FF was collected the day of ER and stored at –80 °C. After thawing, a Sars-Cov2 multiplex RT-PCR using CFX96 (Biorad*) was performed, after RNA extraction using Nimbus (Seegene*). A comprehensive epidemiological evaluation was made afterwards by phone interview and data were recorded and analyzed.
Main results and the role of chance
A total of 183 women was included out of the 214 treated during this period (85.5%). Retrospective epidemiological evaluation showed that 8 patients contracted Covid more than 2 months before the ER, 6 more than 2 months after and only one patient 1 month after ER (diagnosis based on pathognomonic signs as agueusia and anosmia or/and positive PCR ). We observed a prevalence of symptomatic Covid forms in our IVF population of 8.2% during a 6-month period surrounding their IVF cycle. Moreover, until the introduction of systematic testing by RT-PCR for the virus before ER since the end of September 2020, 3 patients have been cancelled out of the 403 planned for positive PCR despite a negative questionnaire, which represents a prevalence of asymptomatic forms on the day of the ER at 0.7%. All the 183 FF tested did not reveal any viral RNA detection, which was reassuring concerning our medical practice and patient compliance and transparency. The absence of detected viral RNA may be due to several reasons: 1) women were not infected the day of ER 2) women had an asymptomatic form of the disease with low viral load 3) FF is not a virus reservoir.
Limitations, reasons for caution
Not all patients were included (85.5%). Post-diagnosis stays uncertain because PCR tests at the beginning of the epidemic were not mandatory and hardly available.
Wider implications of the findings: The absence of viral RNA in FF of women only screened through a symptom questionnaire is reassuring concerning the safety of IVF during Covid pandemic.
Trial registration number
Not applicable
Collapse
Affiliation(s)
- C Fossard
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| | - E Farfour
- FOCH Hospital, Molecular biology laboratory, Suresnes, France
| | - A Benammar
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| | - M Filali
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| | - J Vandame
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| | - P Pirtea
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| | - F Steinberger
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| | - S Ranga
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| | - M Clemenceau
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| | - M Burguion
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| | - M Vasse
- FOCH Hospital, Clinical biology laboratory, Suresnes, France
| | - J M Ayoubi
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| | - M Poulain
- FOCH Hospital, Obstetrics-Gynecology and Reproduction Medicine, Suresnes, France
| |
Collapse
|
29
|
Benammar A, Fanchin R, Filali-Baba M, Vialard F, Fossard C, Vandame J, Pirtea P, Racowsky C, Ayoubi JM, Poulain M. Utilization of in vitro maturation in cases with a FSH receptor mutation. J Assist Reprod Genet 2021; 38:1311-1321. [PMID: 34089127 DOI: 10.1007/s10815-021-02249-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2021] [Accepted: 05/26/2021] [Indexed: 10/21/2022] Open
Abstract
PURPOSE To identify the FSH receptor (FSHR) variant and efficacy of in vitro maturation (IVM) in a 28-year-old woman with secondary amenorrhea, primary infertility, and ovarian resistance to FSH, and to analyze the genotype-to-phenotype relationship in cases of FSHR mutation for the development of an IVM algorithm for use in patients with gonadotropin resistance syndrome (GRS). METHODS Oocytes retrieved after menstruation induction with norethisterone, followed by daily estrogen and an ovulatory trigger, underwent IVM, ICSI, and culture in a time-lapse (TL) incubator. Embryo transfers were performed on day 2, and after thawing on day 5. Genes associated with disorders of sex development were sequenced for both the patient and her parents. All reported cases of FSHR mutation were analyzed to investigate genotype/phenotypic relationships. RESULTS After ovum pickup, seven of 16 oocytes matured and all fertilized. After unsuccessful day 2 transfer, our patient delivered with a thawed day 5 blastocyst, the sole embryo without abnormal TL phenotypes. Genetic analysis revealed a new composite heterozygous FSHR variant. Analysis of our patient case with published cases of GRS revealed associations among FSHR variant genotype, location on the FSHR, functionality of tested variants, and type of amenorrhea. An algorithm for application of IVM for GRS patients was developed. CONCLUSIONS We report two novel variants of the FSHR. Although IVM successfully matured some oocytes, only one resulted in an embryo with normal TL phenotypes. We recommend FSHR genetic testing in GRS patients, which will help guide their suitability for IVM.
Collapse
Affiliation(s)
- Achraf Benammar
- Department of Gyneacology, Obstetrics and Reproductive Medicine, Hospital Foch, 92150, Suresnes, France.
| | - Renato Fanchin
- Department of Gyneacology, Obstetrics and Reproductive Medicine, Hospital Foch, 92150, Suresnes, France
| | - Meryem Filali-Baba
- Department of Gyneacology, Obstetrics and Reproductive Medicine, Hospital Foch, 92150, Suresnes, France
| | - François Vialard
- Université Paris-Saclay, INRAE, ENVA, UVSQ, BREED, 78350, Jouy-en-Josas, France.,Genetics Federation, CHI de Poissy St Germain en Laye, 78303, Poissy, France
| | - Camille Fossard
- Department of Gyneacology, Obstetrics and Reproductive Medicine, Hospital Foch, 92150, Suresnes, France
| | - Jessica Vandame
- Department of Gyneacology, Obstetrics and Reproductive Medicine, Hospital Foch, 92150, Suresnes, France
| | - Paul Pirtea
- Department of Gyneacology, Obstetrics and Reproductive Medicine, Hospital Foch, 92150, Suresnes, France
| | - Catherine Racowsky
- Department of Gyneacology, Obstetrics and Reproductive Medicine, Hospital Foch, 92150, Suresnes, France
| | - Jean-Marc Ayoubi
- Department of Gyneacology, Obstetrics and Reproductive Medicine, Hospital Foch, 92150, Suresnes, France.,Université Paris-Saclay, INRAE, ENVA, UVSQ, BREED, 78350, Jouy-en-Josas, France
| | - Marine Poulain
- Department of Gyneacology, Obstetrics and Reproductive Medicine, Hospital Foch, 92150, Suresnes, France.,Université Paris-Saclay, INRAE, ENVA, UVSQ, BREED, 78350, Jouy-en-Josas, France
| |
Collapse
|
30
|
Carbonnel M, Cornet N, Revaux A, Favre-Inhofer A, Galio L, Raliou M, Couturier-Tarrade A, Giraud-Delville C, Charpigny G, Gelin V, Dubois O, Hersant B, Bosc R, Coscas R, Vialard F, Chavatte-Palmer P, Richard C, Sandra O, Ayoubi JM. Analysis of blood parameters and molecular endometrial markers during early reperfusion in two ovine models of uterus transplantation. PLoS One 2021; 16:e0251474. [PMID: 34003831 PMCID: PMC8130915 DOI: 10.1371/journal.pone.0251474] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2021] [Accepted: 04/27/2021] [Indexed: 11/30/2022] Open
Abstract
The dissection of the veins is the trickiest step of Uterine transplantation (UTx). Performing the anastomosis of a single uterine vein could bring a therapeutic benefit and simplification of surgery and serve for managing unilateral venous thromboses. The objectives of this project were to evaluate the expression of early markers of ischemia-reperfusion and to compare findings following one or two vein anastomoses. Orthotopic uterine auto-transplantations were performed on an ovine model with anastomosis of either two (group 1) or one utero-ovarian veins (group 2). Blood gases, histology and ischemia- reperfusion markers transcripts (PTGS2, IL6, IL8, SOD2, C3, BAX/BCL2 and TLR4) were analyzed as well as PTGS2 protein expression using Western Blot and fluorescence immunolocalization on endometrial biopsies after 3h of reperfusion. Ten ewes were included in the experimentation, 4 were in group1, 3 in group 2, the others being sham operated controls. No significant differences were observed between the two phenotypes. Based on these results, the anastomosis of one single uterine vein appears to be an approach consistent with short-term graft survival. Further experiments will be needed to confirm the reliability of this approach, especially the long-term follow-up of the uterine graft including its ability to support gestation to term.
Collapse
Affiliation(s)
- Marie Carbonnel
- Department of Gynaecology and Obstetrics, Foch Hospital, Suresnes, France
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
- * E-mail:
| | - Nathalie Cornet
- Department of Gynaecology and Obstetrics, Foch Hospital, Suresnes, France
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Aurélie Revaux
- Department of Gynaecology and Obstetrics, Foch Hospital, Suresnes, France
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
| | - Angéline Favre-Inhofer
- Department of Gynaecology and Obstetrics, Foch Hospital, Suresnes, France
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Laurent Galio
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Mariam Raliou
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Anne Couturier-Tarrade
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Corinne Giraud-Delville
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Gilles Charpigny
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Valérie Gelin
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Olivier Dubois
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Barbara Hersant
- Department of Plastic, Reconstructive, Aesthetic and Maxillofacial Surgery, Henri Mondor Hospital, Créteil, France
| | - Romain Bosc
- Department of Plastic, Reconstructive, Aesthetic and Maxillofacial Surgery, Henri Mondor Hospital, Créteil, France
| | - Raphael Coscas
- Department of Vascular Surgery, Ambroise Paré University Hospital, Boulogne-Billancourt, France
- UMR 1018, Inserm-Paris11 - CESP, Versailles Saint-Quentin-en-Yvelines University, Paris-Saclay University, Boulogne-Billancourt, France
| | - François Vialard
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Pascale Chavatte-Palmer
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Christophe Richard
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Olivier Sandra
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
- Ecole Nationale Vétérinaire d’Alfort, BREED, Maisons-Alfort, France
| | - Jean-Marc Ayoubi
- Department of Gynaecology and Obstetrics, Foch Hospital, Suresnes, France
- Université Paris-Saclay, UVSQ, INRAE, BREED, Jouy-en-Josas, France
| |
Collapse
|
31
|
Stochino-Loi E, Major AL, Gillon TER, Ayoubi JM, Feki A, Bouquet de Joliniere J. Metformin, the Rise of a New Medical Therapy for Endometriosis? A Systematic Review of the Literature. Front Med (Lausanne) 2021; 8:581311. [PMID: 34046415 PMCID: PMC8144644 DOI: 10.3389/fmed.2021.581311] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2020] [Accepted: 04/14/2021] [Indexed: 11/13/2022] Open
Abstract
Medical treatments for endometriosis aim to control pain symptoms and stop progression of endometriotic lesions. However, their adverse effects and their contraceptive effect in women who desire pregnancy, limit their long terms use. Although there is only one study investigating the effects of metformin on women with endometriosis, metformin seems to have a unique therapeutic potential. It may be a helpful anti-inflammatory and antiproliferative agent in the treatment of endometriosis. As such metformin may be more beneficial thanks to the lack of serious side effects.
Collapse
Affiliation(s)
- Emanuela Stochino-Loi
- Department of Obstetrics and Gynecology, Cantonal Hospital, University of Fribourg, Fribourg, Switzerland
| | - Attila L Major
- Department of Obstetrics and Gynecology, Cantonal Hospital, University of Fribourg, Fribourg, Switzerland.,Femina Gynecology Center, Geneva, Switzerland
| | - Tessa E R Gillon
- Department of Obstetrics and Gynecology, Cantonal Hospital, University of Fribourg, Fribourg, Switzerland
| | - Jean-Marc Ayoubi
- Department of Obstetrics and Gynecology, Foch Hospital, University of West Paris, Suresnes, France
| | - Anis Feki
- Department of Obstetrics and Gynecology, Cantonal Hospital, University of Fribourg, Fribourg, Switzerland
| | - Jean Bouquet de Joliniere
- Department of Obstetrics and Gynecology, Cantonal Hospital, University of Fribourg, Fribourg, Switzerland
| |
Collapse
|
32
|
Murtada R, Carbonnel M, Revaux A, Favre-Inhofer A, Ayoubi JM. Managing a Department of Obstetrics and Gynecology in Times of COVID-19 Outbreak: The Foch Hospital Experience. Front Surg 2021; 8:564145. [PMID: 33928113 PMCID: PMC8076786 DOI: 10.3389/fsurg.2021.564145] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2020] [Accepted: 03/17/2021] [Indexed: 11/13/2022] Open
Abstract
Departments of Gynecology and Obstetrics, as other departments, were faced with a major challenge at the outbreak of the COVID-19 pandemic. Fast restructuring was necessary in order to provide the means for COVID-related care. In this article we share our 1-year experience in reshaping our activities, managing healthcare workers and securing a pathway for pregnant patients, including potential, and confirmed COVID-19 cases. Priorities were set on ensuring patients' and healthcare workers' safety. Key containment measures included facemasks, systematic screening, dedicated spaces for COVID-19 cases with reinforced measures and vaccination campaign.
Collapse
Affiliation(s)
- Rouba Murtada
- Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France
| | - Marie Carbonnel
- Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France
| | - Aurélie Revaux
- Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France
| | | | - Jean-Marc Ayoubi
- Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France
| |
Collapse
|
33
|
Favre-Inhofer A, Carbonnel M, Murtada R, Revaux A, Asmar J, Ayoubi JM. Sacrospinous ligament fixation: medium and long-term anatomical results, functional and quality of life results. BMC Womens Health 2021; 21:66. [PMID: 33579252 PMCID: PMC7881556 DOI: 10.1186/s12905-021-01195-7] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/16/2020] [Accepted: 01/25/2021] [Indexed: 11/10/2022]
Abstract
BACKGROUND To evaluate the medium and long-term anatomical results of sacrospinous ligament fixation (SLF) and its impact on quality of life (QoL). METHODS We conducted a retrospective and observational single centre study. Fifty-nine patients were interviewed using the Pelvic Floor Distress Inventory and Pelvic Floor Impact Questionnaire and underwent physical examination using POP-Q several years after SLF. Primary outcome was the comparison of anatomic results of SLF at medium-term (group 1: 1-5 years after surgery) and long-term (group 2: more than 5 years after surgery). The secondary outcome was QoL evaluation. RESULTS The overall recurrence and complication rates were respectively 22% and 10%, with no significant differences between groups 1 and 2. The recurrence rate was similar in both groups [twelve (35%) in group 1 and nine (20%) in group 2, p = 0.09]. Two patients (12%) in the recurrence and none in the no recurrence group had clinical symptoms (p = 0.08). Two patients (12%) in the recurrence and one patient (2%) in the no-recurrence group had a significant impact on their quality of life (p = 0.12). CONCLUSION This study showed sustainable anatomic and functional results of SLF in medium and long-term analysis with overall low morbidity.
Collapse
Affiliation(s)
- Angeline Favre-Inhofer
- Department of Obstetrics Gynecology and Reproductive Medecine, Hospital Foch, Suresnes, France. .,University Versailles, Saint-Quentin en Yvelines, France.
| | - Marie Carbonnel
- Department of Obstetrics Gynecology and Reproductive Medecine, Hospital Foch, Suresnes, France.,University Versailles, Saint-Quentin en Yvelines, France
| | - Rouba Murtada
- Department of Obstetrics Gynecology and Reproductive Medecine, Hospital Foch, Suresnes, France
| | - Aurélie Revaux
- Department of Obstetrics Gynecology and Reproductive Medecine, Hospital Foch, Suresnes, France.,University Versailles, Saint-Quentin en Yvelines, France
| | - Jennifer Asmar
- Department of Obstetrics Gynecology and Reproductive Medecine, Hospital Foch, Suresnes, France
| | - Jean-Marc Ayoubi
- Department of Obstetrics Gynecology and Reproductive Medecine, Hospital Foch, Suresnes, France.,University Versailles, Saint-Quentin en Yvelines, France
| |
Collapse
|
34
|
Carbonnel M, Brot D, Benedetti C, Kennel T, Murtada R, Revaux A, Ayoubi JM. Risks factors FOR wound complications after cesarean section. J Gynecol Obstet Hum Reprod 2020; 50:101987. [PMID: 33212324 DOI: 10.1016/j.jogoh.2020.101987] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2020] [Revised: 11/05/2020] [Accepted: 11/11/2020] [Indexed: 12/14/2022]
Abstract
OBJECTIVE The primary outcome was to determine risks factors for wound complications after cesarean section. Secondary outcome was the management of these complications. STUDY DESIGN We performed a retrospective cohort study of consecutive cesarean deliveries performed at a secondary care facility between June 2017 and June 2019. Composite wound complications included infection, disruption and fluid collection occurring 30 days post-operatively. Medical records were reviewed and data including patient demographics, comorbidities, intra-partum characteristics were evaluated as potential risk factors for wound complications using multivariate logistic regression. Secondarily, post-operative management of wound complications was described. RESULTS Among 1520 patients undergoing cesarean section during the period of study, 67 developed wound complications (4.4 %). Mean Duration of local wound care was 41.35 days (2-95). Mean number of wound care related visits in our hospital was 4.85(1-11). Multivariate logistic regression analysis showed 2 significant independant risk factors: preeclampsia with OR 5.60, 95 % CI 2.83, 11.11 (p:<0.001), and premature rupture of the membranes with OR 9.76, 95 % CI 2.13, 44.77 (p: 0.003). CONCLUSION Preeclampsia and premature rupture of the membrane were independent risk factors for wound complications after cesarean section. Information regarding higher rates of wound complications and preventive measures should be provided to high-risk women prior to surgery.
Collapse
Affiliation(s)
- Marie Carbonnel
- Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Foch, Suresnes and University Versailles, Saint-Quentin en Yvelines, France.
| | - Domitille Brot
- Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Foch, Suresnes and University Versailles, Saint-Quentin en Yvelines, France
| | - Charlotte Benedetti
- Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Foch, Suresnes and University Versailles, Saint-Quentin en Yvelines, France
| | - Titouan Kennel
- Department of Clinic Research, Foch Hospital, Suresnes, France
| | - Rouba Murtada
- Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Foch, Suresnes and University Versailles, Saint-Quentin en Yvelines, France
| | - Aurelie Revaux
- Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Foch, Suresnes and University Versailles, Saint-Quentin en Yvelines, France
| | - Jean-Marc Ayoubi
- Department of Obstetrics Gynecology and Reproductive Medicine, Hospital Foch, Suresnes and University Versailles, Saint-Quentin en Yvelines, France
| |
Collapse
|
35
|
Elia D, Gambiacciani M, Ayoubi JM, Berreni N, Bohbot JM, Descamps P, Druckmann R, Geoffrion H, Haab F, Heiss N, Rygaloff N, Russo E. Female urine incontinence: vaginal erbium laser (VEL) effectiveness and safety. Horm Mol Biol Clin Investig 2020; 41:/j/hmbci.ahead-of-print/hmbci-2020-0012/hmbci-2020-0012.xml. [PMID: 33119542 DOI: 10.1515/hmbci-2020-0012] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/13/2020] [Accepted: 05/06/2020] [Indexed: 11/15/2022]
Abstract
Urinary incontinence is a common health problem that impacts the quality of life of women at different ages. Its physiopathology is not unequivocal, and it is necessary to consider the stress urinary incontinence (SUI), the overactive bladder syndrome and the mixed incontinence (MUI). According to the type of incontinence, its impact on the quality of life and age of the patients, therapeutic strategies are currently summarized in physiotherapy, surgery and drug treatments. We already know the benefit/risk ratio of each of these strategies. Our objective is to evaluate the potential effectiveness and safety of the VEL, an innovative vaginal laser technique (VEL - Vaginal Erbium Laser, erbium yttrium-aluminum-garnet -Er: YAG) a non-invasive laser proposed as a treatment for SUI, overactive bladder syndrome and MUI. The mechanisms of action of lasers are discussed in general and those of VEL in particular with the description of the Smooth® mode. To do this, we have collected the 21 published studies including the first randomized vs. placebo and two pilot studies of intra-urethral VEL. In conclusion: VEL procedures already have their place between the rehabilitation of the perineal floor and surgery. Further properly sized, randomized studies are needed to evaluate the laser treatments in comparison with other therapies, as well as to assess the duration of the therapeutic effects and the safety of repeated applications.
Collapse
Affiliation(s)
- David Elia
- Vaginal Erbium Laser Academy France, Paris, France
| | | | | | | | | | | | | | | | | | - Niko Heiss
- Vaginal Erbium Laser Academy France, Paris, France
| | | | | |
Collapse
|
36
|
Poulain M, Vandame J, Tran C, Koutchinsky S, Pirtea P, Ayoubi JM. Fertility preservation in borderline ovarian tumor patients and survivors. Horm Mol Biol Clin Investig 2020; 43:179-186. [PMID: 32628631 DOI: 10.1515/hmbci-2019-0072] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2019] [Accepted: 05/02/2020] [Indexed: 12/24/2022]
Abstract
Borderline ovarian tumors (BOTs) represent around 15% of all epithelial ovarian cancer. Around one third of those patients is under 40 and has not completed childbearing when the tumor is diagnosed. Cancer survivors are more and more concerned about their future fertility since a large proportion of those with BOTs are young. Whatever the tumor stage, information regarding future fertility after treatment and fertility preservation (FP) options must be delivered to all patients before treatment. A multidisciplinary team will discuss and propose personalized treatment and FP strategies. Nowadays, the FP options offered to patients with BOT are the followings: i) minimal invasive conservative surgery, ii) oocyte cryopreservation after controlled ovarian stimulation (COS) or in vitro maturation (IVM) and iii) ovarian tissue cryopreservation. Generally, the most common strategy to preserve future fertility is represented by minimal invasive conservative surgery. However, with the remarkable success and evolution of assisted reproductive technologies (ART) - notably progress and efficiency in COS and oocyte vitrification - have led to offer another potential approach for FP consisting in oocyte cryopreservation. Several COS protocols, such as random start or dual stimulation associating tamoxifen or aromatase inhibitors with gonadotropins provide similar results when compared to standard protocols while providing safety by minimizing the risk of high estrogen exposure. When COS is contraindicated, oocyte cryopreservation can still be possible throw IVM. Even though, oocyte competence after IVM is lower than that obtained after COS. A less used approach is cryopreservation of ovarian tissue, consisting in freezing ovarian cortex fragments for a future thawing and graft. Some concerns and limitations regard the ovarian cortex graft and the risk of reintroducing malignant cells once performed. Nonetheless, the latter it is the only option in prepubertal patients.
Collapse
Affiliation(s)
- Marine Poulain
- FOCH Hospital, Gynecology Obstetric and Reproductive Medical Unit Department, Suresnes, France
- Université Paris Saclay, UVSQ, INRAE, BREED, 78350, Jouy-en-Josas, France - ENVA, BREED, 94700, Maison-Alfort, France
| | - Jessica Vandame
- FOCH Hospital, Gynecology Obstetric and Reproductive Medical Unit Department, Suresnes, France
| | - Chloé Tran
- FOCH Hospital, Gynecology Obstetric and Reproductive Medical Unit Department, Suresnes, France
| | - Sonia Koutchinsky
- FOCH Hospital, Gynecology Obstetric and Reproductive Medical Unit Department, Suresnes, France
| | - Paul Pirtea
- FOCH Hospital, Gynecology Obstetric and Reproductive Medical Unit Department, Suresnes, France
- Université Paris Saclay, UVSQ, INRAE, BREED, 78350, Jouy-en-Josas, France - ENVA, BREED, 94700, Maison-Alfort, France
| | - Jean-Marc Ayoubi
- FOCH Hospital, Gynecology Obstetric and Reproductive Medical Unit Department, Suresnes, France
- Université Paris Saclay, UVSQ, INRAE, BREED, 78350, Jouy-en-Josas, France - ENVA, BREED, 94700, Maison-Alfort, France
| |
Collapse
|
37
|
Carbonnel M, Dahm-Kähler P, Revaux A, Brännström M, Ayoubi JM. Adapting surgical skills from robotic-assisted radical hysterectomy in cervical cancer to uterine transplantation: a look to an optimistic future! J Robot Surg 2020; 14:841-847. [PMID: 32088836 DOI: 10.1007/s11701-020-01058-7] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/29/2019] [Accepted: 02/15/2020] [Indexed: 12/20/2022]
Abstract
Uterus transplantation (UTx) is the first treatment for absolute uterine factor infertility. The first birth after human UTx in Sweden occurred in 2014 and very favourable results of the Swedish trial performed with laparotomy raised great hope. Several teams are leading their own trial among the world, but UTx is still in its experimental phase. Surgical intervention needs to be optimized. The long surgical duration (> 10 h), vascular dissection and risks of ureteral damages for live donors are major drawbacks. Minimal invasive surgery by means of robotic-assisted laparoscopy for live donors could become an improved option. Our collaborative Swedish-French team has initiated efforts to introduce minimal invasive surgery in one trial in Sweden and one in France. UTx is somewhat similar to a radical colpohysterectomy for arterial dissection. We describe a robotic-assisted radical colpohysterectomy and its transposition to uterus retrieval in a living donor. We report our experience on nine cases that were completed prior to our French UTx robot-assisted trial.
Collapse
Affiliation(s)
- Marie Carbonnel
- Department of Obstetrics and Gynecology, Foch Hospital, Suresnes, France.
| | - Pernilla Dahm-Kähler
- Department of Obstetrics and Gynecology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden
| | - Aurelie Revaux
- Department of Obstetrics and Gynecology, Foch Hospital, Suresnes, France
| | - Mats Brännström
- Department of Obstetrics and Gynecology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden
| | - Jean-Marc Ayoubi
- Department of Obstetrics and Gynecology, Foch Hospital, Suresnes, France
| |
Collapse
|
38
|
Revaux A, Carbonnel M, Kanso F, Naoura I, Asmar J, Kadhel P, Ayoubi JM. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: an update. Horm Mol Biol Clin Investig 2020; 41:hmbci-2019-0028. [PMID: 32083444 DOI: 10.1515/hmbci-2019-0028] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2019] [Accepted: 12/03/2019] [Indexed: 01/26/2023]
Abstract
In the treatment of advanced-stage epithelial ovarian cancer (EOC)-associated surgery and chemotherapy with intravenous platinum/taxane-based therapy most patients had early or late recurrence. Prevention of progression and recurrence is a major objective for the management of EOC. Recently, many clinical studies have evaluated the strategy with hyperthermic intraoperative intraperitoneal (IP) drug delivery. This is an update of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in EOC and a view for future strategies. Until recently studies on HIPEC in patients with EOC were mostly retrospective and heterogeneous. Thanks to recent clinical trials, it is reasonable to conclude that surgical cytoreduction and HIPEC is an interesting approach in the management of EOC without increasing morbidity.
Collapse
Affiliation(s)
- Aurélie Revaux
- Department of Gynecology and Obstetrics, Foch Hospital, 40 Rue Worth, 92150 Suresnes, France.,Faculté de Médecine Paris Ouest (UVSQ), Versailles, France
| | - Marie Carbonnel
- Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.,Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France
| | - Frédéric Kanso
- Department of Digestive Surgery, Foch Hospital, Suresnes, France
| | - Iptissem Naoura
- Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.,Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France
| | - Jennifer Asmar
- Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.,Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France
| | - Philippe Kadhel
- Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.,Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France.,CHU de Pointe-à-Pitre, Univ Antilles, Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail) - UMR_S 1085, Pointe-à-Pitre, France
| | - Jean-Marc Ayoubi
- Faculté de Médecine Paris Ouest (UVSQ), Versailles, France.,Department of Gynecology and Obstetrics, Foch Hospital, Suresnes, France
| |
Collapse
|
39
|
Bellil H, Herve B, Herzog E, Ayoubi JM, Vialard F, Poulain M. A high level of tetrasomy 9p mosaicism but no clinical manifestations other than moderate oligozoospermia with chromosomally balanced sperm: a case report. J Assist Reprod Genet 2020; 37:573-577. [PMID: 31981038 DOI: 10.1007/s10815-020-01690-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2019] [Accepted: 01/04/2020] [Indexed: 11/29/2022] Open
Abstract
Tetrasomy 9p (ORPHA: 3310) (i(9p)) is a rare chromosomal imbalance. It is characterized by the presence of a supernumerary chromosome incorporating two copies of the short arm of chromosome 9 and is usually present in a mosaic state postnatally. Depending on the level of mosaicism, the phenotype ranges from mild developmental delay to multiple congenital anomalies with severe intellectual disability. Here, we report on a patient diagnosed with i(9p) mosaicism after the recurrent failure of in vitro fertilization. Although the patient's clinical phenotype was normal, the level of mosaicism varied greatly from one tissue to another. A sperm analysis evidenced subnormal spermatogenesis with chromosomally balanced spermatozoa and no risk of transmission to the offspring. Although individuals with i(9p) and no clinical manifestations have rarely been described, the prenatal diagnosis of this abnormality in the absence of ultrasound findings raises a number of questions.
Collapse
Affiliation(s)
- Hela Bellil
- Université Paris-Saclay, INRAE, ENVA, UVSQ, BREED, 78350, Jouy-en-Josas, France.,Genetics Federation, CHI de Poissy St Germain en Laye, F-78303, Poissy, France
| | - Bérenice Herve
- Université Paris-Saclay, INRAE, ENVA, UVSQ, BREED, 78350, Jouy-en-Josas, France.,Genetics Federation, CHI de Poissy St Germain en Laye, F-78303, Poissy, France
| | - Elodie Herzog
- Department of Gyneacology, Obstetrics and Reproductive Medicine, Hopital Foch, F-92150, Suresnes, France
| | - Jean-Marc Ayoubi
- Université Paris-Saclay, INRAE, ENVA, UVSQ, BREED, 78350, Jouy-en-Josas, France.,Department of Gyneacology, Obstetrics and Reproductive Medicine, Hopital Foch, F-92150, Suresnes, France
| | - François Vialard
- Université Paris-Saclay, INRAE, ENVA, UVSQ, BREED, 78350, Jouy-en-Josas, France. .,Genetics Federation, CHI de Poissy St Germain en Laye, F-78303, Poissy, France.
| | - Marine Poulain
- Université Paris-Saclay, INRAE, ENVA, UVSQ, BREED, 78350, Jouy-en-Josas, France.,Department of Gyneacology, Obstetrics and Reproductive Medicine, Hopital Foch, F-92150, Suresnes, France
| |
Collapse
|
40
|
Sebbag L, Even M, Fay S, Naoura I, Revaux A, Carbonnel M, Pirtea P, de Ziegler D, Ayoubi JM. Early Second-Look Hysteroscopy: Prevention and Treatment of Intrauterine Post-surgical Adhesions. Front Surg 2019; 6:50. [PMID: 31475154 PMCID: PMC6706867 DOI: 10.3389/fsurg.2019.00050] [Citation(s) in RCA: 20] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2019] [Accepted: 07/30/2019] [Indexed: 12/19/2022] Open
Abstract
Introduction: Intra-uterine adhesion (IUA) is one of the main causes of secondary infertility. The aim of this study was to evaluate the prevalence of IUA developing in women undergoing hysteroscopic resection for submucous myomas, polyps, and intrauterine synechiae and test the efficacy of second look hysteroscopy for diagnosing and treating post-surgical adhesions. Materials and Methods: We retrospectively collected data from reproductive age women who had a second look office hysteroscopy following hysteroscopic resection for myoma, polyp, or IUA at Foch hospital (Suresnes, France) between 2009 and 2017. Results: Six hundred and twenty two reproductive-age women underwent hysteroscopic resection for myoma, polyp, and/or IUA. Among them, 155 women had a second look hysteroscopy. In this group, 29/155 (18.7%) had IUA formation: 17/83 (20.5%) women who underwent hysteroscopic myomectomy, 5/46 (10.9%) women who underwent hysteroscopic polypectomy, and 7/26 (26.9%) women who underwent hysteroscopic lysis of adhesions. These IUA have been lysed by the office hysteroscopy procedure in 16/29 (55.2%) patients: 11/17 (64.7%), 2/5 (40%), and 3/7 (42.9%) in women who underwent hysteroscopic myomectomy, polypectomy and lysis of adhesion, respectively. Conclusion: IUA is a common complication of hysteroscopic surgery. Second look office hysteroscopy is an easy and effective procedure for diagnosing and removing newly formed IUA. It should be recommended for all women undergoing hysteroscopic resection for myomas, polyps, or IUA.
Collapse
Affiliation(s)
- Lauren Sebbag
- Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France
| | - Marc Even
- Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France
| | - Stéphanie Fay
- Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France
| | - Iptissem Naoura
- Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France
| | - Aurélie Revaux
- Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France
| | - Marie Carbonnel
- Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France
| | - Paul Pirtea
- Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France
| | - Dominique de Ziegler
- Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France
| | - Jean-Marc Ayoubi
- Department of Obstetrics, Gynecology and Reproductive Sciences, Foch Hospital, Suresnes, France
| |
Collapse
|
41
|
Ceccaldi PF, Pirtea P, Lemarteleur V, Poulain M, Ziegler DD, Ayoubi JM. Simulation and professional development: added value of 3D modelization in reproductive endocrinology and infertility and assisted reproductive technologies teamwork. Gynecol Endocrinol 2019; 35:559-563. [PMID: 30935263 DOI: 10.1080/09513590.2019.1588874] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
As in other specialties of medicine, there is more to clinical performance in reproductive endocrinology, infertility, and assisted reproductive technologies (REI-ART) than simply the individual knowledge and technical skills. Simulation is commonly used during fellowship training in REI-ART, aiming to produce a virtual cycle of professional development in order to improve patient outcome. With scientific certification and the joint development of evaluation tools, the contribution of digitalization, such as 3 D printing and digital simulators, will facilitate teamwork in REI-ART and enable a better transmission of knowledge in the specialty.
Collapse
Affiliation(s)
- Pierre-François Ceccaldi
- a Simulation Department of Paris Diderot University , ILumens Paris Diderot, Paris , France
- b Obstetrics and Gynecology Department , Beaujon Teaching Hospital, Assistance Publique Hôpitaux de Paris , Paris , France
| | - Paul Pirtea
- c Department of Obstetrics, Gynecology, and Reproductive Medicine , Hôpital Foch, Faculté de Médecine Paris Ouest, (UVSQ) , Suresnes , France
| | - Vincent Lemarteleur
- a Simulation Department of Paris Diderot University , ILumens Paris Diderot, Paris , France
| | - Marine Poulain
- c Department of Obstetrics, Gynecology, and Reproductive Medicine , Hôpital Foch, Faculté de Médecine Paris Ouest, (UVSQ) , Suresnes , France
| | - Dominique De Ziegler
- c Department of Obstetrics, Gynecology, and Reproductive Medicine , Hôpital Foch, Faculté de Médecine Paris Ouest, (UVSQ) , Suresnes , France
| | - Jean-Marc Ayoubi
- c Department of Obstetrics, Gynecology, and Reproductive Medicine , Hôpital Foch, Faculté de Médecine Paris Ouest, (UVSQ) , Suresnes , France
| |
Collapse
|
42
|
Marie-Scemama L, Even M, De La Joliniere JB, Ayoubi JM. Endometriosis and the menopause: why the question merits our full attention. Horm Mol Biol Clin Investig 2019; 37:hmbci-2018-0071. [PMID: 30913034 DOI: 10.1515/hmbci-2018-0071] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2018] [Accepted: 01/20/2019] [Indexed: 12/11/2022]
Abstract
As an estrogen-dependent disease, endometriosis was thought to become less active or regress with the onset of the menopause. However, based on some new data, we are discovering that this pathology can emerge or reappear at this period of life. Clinicians must consider it as a possible cause for cases of pelvic pain, and heavy bleeding. Authors have described a possibility of transformation of the intraperitoneal proliferation into a malignant type with ovarian, bowel and even lung metastasis. The risk of transformation into an ovarian cancer is around 2 or 3%. The role of menopausal hormonal therapy will be discussed as in recurrence in the case of residue existence, especially after incomplete surgery. Is it possible to prescribe hormonal therapy to a menopausal women suffering climacteric symptoms as it could trigger a recurrence of endometriosis and even an increased risk of malignant degeneration? This remains unclear. It is an unresolved therapeutic dilemma; the choice between surgery or medical treatment?
Collapse
Affiliation(s)
- Lydia Marie-Scemama
- Obstetrics & Gynecology, 40 rue Worth Suresnes, France.,Foch Hospital, Suresnes, France
| | - Marc Even
- Obstetrics & Gynecology, 40 rue Worth Suresnes, France.,Foch Hospital, Suresnes, France
| | | | - Jean-Marc Ayoubi
- Gynécologie - Obstétrique & Médecine de la Reproduction, Faculté de Paris Ouest UVSQ Hôpital Foch jm, Suresnes, France
| |
Collapse
|
43
|
Pop A, Carbonnel M, Wang A, Josserand J, Auliac SC, Ayoubi JM. Posterior reversible encephalopathy syndrome associated with reversible cerebral vasoconstriction syndrome in a patient presenting with postpartum eclampsia: A case report. J Gynecol Obstet Hum Reprod 2019; 48:431-434. [PMID: 30905853 DOI: 10.1016/j.jogoh.2019.03.019] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2018] [Revised: 03/12/2019] [Accepted: 03/20/2019] [Indexed: 01/03/2023]
Abstract
Posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction (RCVS) are rare neurological disorders with complex physiopathology which is not yet fully understood. We present here the case of a 31-year-old woman with a bi-amniotic bi-chorial pregnancy who developed immediate postpartum eclampsia after vaginal delivery, associated with RCVS and PRES. Although post-partum is a well-known precipitating factors for these diseases, to our knowledge, there are only few similar cases reported with the association of these syndromes. Repeated MRI scans were instrumental in the final diagnosis of RCVS associated with PRES, allowing us to give the patient the appropriate treatment. These two syndromes have similar symptoms but may have different treatments, thus highlighting the importance of a correct diagnosis.
Collapse
Affiliation(s)
- Antonia Pop
- Department of Gynecology, obstetrics and reproductive medicine, Foch Hospital, Suresnes 92150, France
| | - Marie Carbonnel
- Department of Gynecology, obstetrics and reproductive medicine, Foch Hospital, Suresnes 92150, France.
| | - Adrien Wang
- Department of Neurology, Foch Hospital, Suresnes 92150, France
| | - Julien Josserand
- Department of Anesthesiology, Foch Hospital, Suresnes 92150, France
| | | | - Jean-Marc Ayoubi
- Department of Gynecology, obstetrics and reproductive medicine, Foch Hospital, Suresnes 92150, France
| |
Collapse
|
44
|
Dion L, Tardieu A, Collinet P, Garbin O, Ayoubi JM, Agostini A, Piver P, Aubard Y, Gauthier T, Lavoué V. Uterus transplantation and altruistic surrogacy: Are they complementary or alternative options?-A statement from the CNGOF French Uterus Transplantation Committee. J Gynecol Obstet Hum Reprod 2019; 48:293-295. [PMID: 30771508 DOI: 10.1016/j.jogoh.2019.02.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/18/2019] [Accepted: 02/11/2019] [Indexed: 11/16/2022]
Affiliation(s)
- L Dion
- Service de gynécologie, CHU de Rennes, Hôpital sud, 16 bd de Bulgarie, 35000 Rennes, France
| | - A Tardieu
- Département de gynécologie obstétrique, CHU Limoges, av Dominique Larrey, 87000 Limoges, France; INSERM, UMR-s850, CHU Limoges, 87000 Limoges, France
| | - P Collinet
- Clinique gynécologique, Hôpital Jeanne de Flandre, CHRU Lille, 59037 Lille cedex, France
| | - O Garbin
- Département de gynécologie, pôle de gynécologie obstétrique des Hôpitaux universitaire de Strasbourg, site du cmco, 67091 Strasbourg, France
| | - J M Ayoubi
- Département de gynécologie, Hôpital Foch, 92150 Suresnes, France
| | - A Agostini
- Département de gynécologie obstétrique, Gynécologie CHU de Marseille, Hôpital de la Conception, 13385 Marseille, France
| | - P Piver
- Département de gynécologie obstétrique, CHU Limoges, av Dominique Larrey, 87000 Limoges, France; INSERM, UMR-s850, CHU Limoges, 87000 Limoges, France
| | - Y Aubard
- Département de gynécologie obstétrique, CHU Limoges, av Dominique Larrey, 87000 Limoges, France; INSERM, UMR-s850, CHU Limoges, 87000 Limoges, France
| | - T Gauthier
- Département de gynécologie obstétrique, CHU Limoges, av Dominique Larrey, 87000 Limoges, France; INSERM, UMR-s850, CHU Limoges, 87000 Limoges, France
| | - V Lavoué
- Service de gynécologie, CHU de Rennes, Hôpital sud, 16 bd de Bulgarie, 35000 Rennes, France.
| |
Collapse
|
45
|
Favre-Inhofer A, Carbonnel M, Revaux A, Sandra O, Mougenot V, Bosc R, Gélin V, Rafii A, Hersant B, Vialard F, Chavatte-Palmer P, Richard C, Ayoubi JM. Critical steps for initiating an animal uterine transplantation model in sheep: Experience from a case series. Int J Surg 2018; 60:245-251. [DOI: 10.1016/j.ijsu.2018.11.017] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2018] [Revised: 10/30/2018] [Accepted: 11/11/2018] [Indexed: 12/15/2022]
|
46
|
Dion L, Tardieu A, Piver P, Aubard Y, Ayoubi JM, Garbin O, Agostini A, Collinet P, Gauthier T, Lavoué V. Uterus transplantation: Where do we stand in 2018? J Gynecol Obstet Hum Reprod 2018; 48:11-13. [PMID: 30267772 DOI: 10.1016/j.jogoh.2018.09.008] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2018] [Revised: 09/18/2018] [Accepted: 09/24/2018] [Indexed: 01/29/2023]
Affiliation(s)
- L Dion
- Service de Gynécologie, CHU de Rennes, Hôpital Sud, 16 bd de Bulgarie, 35000 Rennes, France
| | - A Tardieu
- Département de Gynécologie Obstétrique, CHU Limoges, av Dominique Larrey, 87000 Limoges, France; INSERM, UMR-1248, CHU Limoges, 87000 Limoges, France
| | - P Piver
- Département de Gynécologie Obstétrique, CHU Limoges, av Dominique Larrey, 87000 Limoges, France; INSERM, UMR-1248, CHU Limoges, 87000 Limoges, France
| | - Y Aubard
- Département de Gynécologie Obstétrique, CHU Limoges, av Dominique Larrey, 87000 Limoges, France; INSERM, UMR-1248, CHU Limoges, 87000 Limoges, France
| | - J M Ayoubi
- Département de Gynécologie, Hôpital Foch, 92150 Suresnes, France
| | - O Garbin
- Département de Gynécologie, Pôle de Gynécologie Obstétrique des Hôpitaux Universitaire de Strasbourg, Site du CMCO, 67091 Strasbourg, France
| | - A Agostini
- Département de Gynécologie Obstétrique, Gynécologie CHU de Marseille, Hôpital de la Conception, 13385 Marseille, France
| | - P Collinet
- Clinique Gynécologique, Hôpital Jeanne de Flandre, CHRU Lille, 59037 Lille cedex, France
| | - T Gauthier
- Département de Gynécologie Obstétrique, CHU Limoges, av Dominique Larrey, 87000 Limoges, France; INSERM, UMR-1248, CHU Limoges, 87000 Limoges, France
| | - V Lavoué
- Service de Gynécologie, CHU de Rennes, Hôpital Sud, 16 bd de Bulgarie, 35000 Rennes, France.
| | | |
Collapse
|
47
|
Favre-Inhofer A, Carbonnel M, Revaux A, Rafii A, Karpel L, Frydman R, Ayoubi JM. [Uterus transplantation: state of knowledge and ethical reflection]. Rev Prat 2018; 68:657-663. [PMID: 30869260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Uterus transplantation: state of knowledge and ethical reflection. Nowadays is uterine transplantation the only treatment for absolute uterine infertility. This experimental surgery is spreading worldwide since the past two years. The first livebirths from uterus transplantations from living donors in Sweden gave the impetus for more research. Since several team works on the uterine transplantation from living or deceased donors. Uterus transplantation and the choice between live and deceased donor raises up technical and ethical questions.
Collapse
Affiliation(s)
- Angeline Favre-Inhofer
- Service de gynécologieobstétrique et médecine de la reproduction, hôpital Foch, Suresnes, France
| | - Marie Carbonnel
- Service de gynécologieobstétrique et médecine de la reproduction, hôpital Foch, Suresnes, France
| | - Aurelie Revaux
- Service de gynécologieobstétrique et médecine de la reproduction, hôpital Foch, Suresnes, France
| | - Arash Rafii
- Service de gynécologieobstétrique et médecine de la reproduction, hôpital Foch, Suresnes, France
- Weill Cornell Medicine, Education City, Ar-Rayyan, Qatar
| | - Léa Karpel
- Service de gynécologieobstétrique et médecine de la reproduction, hôpital Foch, Suresnes, France
| | - René Frydman
- Service de gynécologieobstétrique et médecine de la reproduction, hôpital Foch, Suresnes, France
| | - Jean-Marc Ayoubi
- Service de gynécologieobstétrique et médecine de la reproduction, hôpital Foch, Suresnes, France
| |
Collapse
|
48
|
Fuchs F, Aouinti S, Souaied M, Keller V, Picot MC, Fries N, Ayoubi JM, Picone O. Association between amniotic fluid evaluation and fetal biometry: a prospective French "Flash" study. Sci Rep 2018; 8:7093. [PMID: 29728591 PMCID: PMC5935749 DOI: 10.1038/s41598-018-25497-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/17/2017] [Accepted: 04/20/2018] [Indexed: 12/16/2022] Open
Abstract
We aimed to study the association between three different methods of assessing the amount of amniotic fluid (subjective method (SM), deepest vertical pocket (DVP) and amniotic fluid index (AFI)) and estimated fetal weight (EFW) (in percentile or Z-score) after adjustment on maternal-fetal parameters. We performed a nationwide cross-sectional study through the French network of obstetric sonographers using the "flash" study method and including low-risk singleton pregnancies from 18-40 weeks. Crude and adjusted odds ratio were computed after stratification upon 2nd and 3rd trimester of pregnancy. 1667 ultrasound scans performed by 65 operators were included. Only Z-score of EFW was significantly associated with SM in both trimesters. For DVP and AFI, Z-score of EFW and male fetal gender was significantly associated with them in 2nd trimester. In the 3rd trimester, both Z-score of EFW and large (LGA) or small for gestational age (SGA) fetus were significantly associated with AFI. and DVP. Overweight woman and class I obesity women were also significantly associated with DVP modification. In conclusion, all three methods of amniotic fluid evaluation are significantly associated to estimated fetal weight. DVP and AFI appeared equivalent except that maternal-fetal factors seemed to have a higher impact in DVP than AFI.
Collapse
Affiliation(s)
- Florent Fuchs
- Department of Obstetrics and Gynecology, Montpellier University Hospital Center, 371 Avenue du Doyen Gaston Giraud, Montpellier, France.
- Inserm, CESP Centre for research in Epidemiology and Population Health, U1018, Reproduction and child development, Villejuif, France.
| | - Safa Aouinti
- Clinical Research and Epidemiology Unit (URCE), CHU Montpellier, Univ Montpellier, Montpellier, France
| | - Manel Souaied
- Department of Obstetrics and Gynecology, Hopital Foch, 40 rue Worth, Suresnes, France
| | - Valentin Keller
- Department of Obstetrics and Gynecology, Hopital Foch, 40 rue Worth, Suresnes, France
| | - Marie-Christine Picot
- Clinical Research and Epidemiology Unit (URCE), CHU Montpellier, Univ Montpellier, Montpellier, France
| | - Nicolas Fries
- Department of Obstetrics and Gynecology, Montpellier University Hospital Center, 371 Avenue du Doyen Gaston Giraud, Montpellier, France
- Collège Français d'Echographie Foetale, CFEF, France
| | - Jean-Marc Ayoubi
- Department of Obstetrics and Gynecology, Hopital Foch, 40 rue Worth, Suresnes, France
| | - Olivier Picone
- Department of Obstetrics and Gynecology, Hopital Foch, 40 rue Worth, Suresnes, France
- Collège Français d'Echographie Foetale, CFEF, France
- EA2493, UFR des sciences de la santé Simone Veil, Université Versailles Saint Quentin en Yvelines, Versailles, France
- Department of Obstetrics and Gynecology. Louis Mourier Hospital, Paris Nord Val de seine University Hospitals, APHP, Paris-Diderot University, 178 rue des Renouillers Colombes, Paris, France
| |
Collapse
|
49
|
Khediri Z, Vauloup-Fellous C, Benachi A, Ayoubi JM, Mandelbrot L, Picone O. Adverse effects of maternal enterovirus infection on the pregnancy outcome: a prospective and retrospective pilot study. Virol J 2018; 15:70. [PMID: 29661198 PMCID: PMC5902830 DOI: 10.1186/s12985-018-0978-7] [Citation(s) in RCA: 13] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2017] [Accepted: 04/03/2018] [Indexed: 11/10/2022] Open
Abstract
Background Enteroviruses account for about one billion infections worldwide each year, the majority remain asymptomatic. Data on enterovirus infections during pregnancy appear to be very rare. Several cases have been reported in the literature of fetal and neonatal complications attributed to these viruses, but prospective data on these infections during pregnancy are not available. Objective To estimate the prevalence of enterovirus infections in febrile syndromes in pregnant women, and in case of in utero fetal death (IUFD). Methods Ttri-centric observational cohort study. We performed prospective inclusion for patients with fever during a four-month period. We also analyzed the amniotic fluid in patients with unexplained IUFD retrospectively during a five-year period. Investigations of enteroviruses are made by RT-PCR from routine biological samples (amniocentesis, RT-PCR in maternal blood or CSF). Results Prospectively, 33 patients were included during the study period. We have identified 4 cases of confirmed enterovirus infection (12.4%). We have recorded a severe form of perinatal enterovirus infection involving the vital prognosis of the newborn. In the retrospective cohort of 75 IUFD cases, we had only one case of enterovirus-positive RT-PCR in amniotic fluid during 5 years, meaning a frequency of 1.3%. We did not had any positive EV case in case of early miscarriage, but the limited number of inclusions cannot help us to conclude. Conclusion Enteroviruses are probably an underestimated cause of obstetric and neonatal complications. Investigation of enterovirus by PCR should be discussed during pregnancy and peripartum in case of febrile syndrome with no obvious bacterial cause, and unexplained IUFD.
Collapse
Affiliation(s)
- Z Khediri
- Service de gynécologie et obstétrique and Risk in pregnancy university department, Hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 178, rue des Renouillers, 92700, Colombes, France.,Université Paris-Diderot, 75013, Paris, France
| | - C Vauloup-Fellous
- Inserm U1193, virologie, WHO Rubella NRL, National Reference Laboratory for Maternofetal Rubella Infections, AP-HP, hôpital Paul-Brousse, groupe hospitalier universitaire Paris-Sud, université Paris-Sud, 94804, Villejuif, France.,Groupe de Recherche sur les Infections Pendant la Grossesse (GRIG), Vélizy, France
| | - A Benachi
- Department of Obstetrics, Gynecology and Reproductive Medicine and Centre, maladies rares : hernie de coupole diaphragmatique, hôpital Antoine-Béclère, AP-HP, université Paris Sud, 157, rue de la Porte-de-Trivaux, 92140, Clamart, France
| | - J M Ayoubi
- Department of obstetrics and gynecology, hôpital Foch, 92120, Suresnes, France.,EA2493, UFR des sciences de la santé Simone-Veil, université Versailles Saint-Quentin-en-Yvelines, 78180, Montigny-le-Bretonneux, France
| | - L Mandelbrot
- Service de gynécologie et obstétrique and Risk in pregnancy university department, Hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 178, rue des Renouillers, 92700, Colombes, France.,IAME (Infection, Antimicrobials, Modelling, Evolution), INSERM, UMR 1137 - UFR de Médecine Paris 7 Denis Diderot, 16 rue Henri Huchard, B.P. 416 - 75870, Paris cedex 18, France.,Groupe de Recherche sur les Infections Pendant la Grossesse (GRIG), Vélizy, France
| | - O Picone
- Service de gynécologie et obstétrique and Risk in pregnancy university department, Hôpital Louis-Mourier, Assistance publique-Hôpitaux de Paris, 178, rue des Renouillers, 92700, Colombes, France. .,IAME (Infection, Antimicrobials, Modelling, Evolution), INSERM, UMR 1137 - UFR de Médecine Paris 7 Denis Diderot, 16 rue Henri Huchard, B.P. 416 - 75870, Paris cedex 18, France.
| |
Collapse
|
50
|
Adda-Herzog E, Poulain M, de Ziegler D, Ayoubi JM, Fanchin R. Premature progesterone elevation in controlled ovarian stimulation: to make a long story short. Fertil Steril 2018; 109:563-570. [DOI: 10.1016/j.fertnstert.2018.02.132] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/15/2018] [Revised: 02/21/2018] [Accepted: 02/21/2018] [Indexed: 10/17/2022]
|